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ABSTRACT 
Consumers’ increasing awareness of healthiness and sustainability of food 
presents a great challenge to food industry to develop healthier, biologically 
active and sustainable food products. Bioactive peptides derived from food 
proteins are known to possess various biological activities. Among the 
activities, the most widely studied are antioxidant activities and angiotensin I 
converting enzyme (ACE) inhibitory activity related to blood pressure 
regulation and antihypertensive effects. Meanwhile, vast amounts of by-
products with high protein content are produced in food industry, for example 
potato and rapeseed industries. The utilization of these by-products could be 
enhanced by using them as a raw material for bioactive peptides. 
The objective of the present study was to investigate the production of 
bioactive peptides with ACE inhibitory and antioxidant properties from 
rapeseed and potato proteins. Enzymatic hydrolysis and fermentation were 
utilized for peptide production, ultrafiltration and solid-phase extraction were 
used to concentrate the active peptides, the peptides were fractionated with 
liquid chromatographic processes, and the peptides with the highest ACE 
inhibitory capacities were putified and analyzed with Maldi-Tof/Tof to identify 
the active peptide sequences. The bioavailability of the ACE inhibitory 
peptides was elucidated with an in vitro digestion model and the 
antihypertensive effects in vivo of rapeseed peptide concentrates were 
investigated with a preventive premise in 2K1C rats.   
The results showed that rapeseed and potato proteins are rich sources of 
ACE inhibitory and antioxidant peptides. Enzymatic hydrolysis released the 
peptides effectively whereas fermentation produced lower activities.The native 
enzymes of potato were also able to release ACE inhibitory peptides from 
potato proteins without the addition of exogenous enzymes. The rapeseed 
peptide concentrate was capable of preventing the development of hypertension 
in vivo in 2K1C rats, but the quality of rapeseed meal used as raw material was 
found to affect considerably the antihypertensive effects and the composition of 
the peptide fraction. 
Suomenkielinen abstrakti 
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SUOMENKIELINEN ABSTRAKTI 
Bioaktiiviset peptidit ovat ruoan proteiinien rakenneosia, joilla tiedetään olevan 
biologisia vaikutuksia. Eniten tutkittuihin vaikutuksiin lukeutuu Angiotensiini 
I:ä muuntelevan entsyymin (ACE) toimintaa estävä vaikutus, joka liittyy 
verenpaineen säätelyyn ja verenpaineen laskuun. Peptideillä on laajalti todettu 
myös antioksidatiivisia vaikutuksia, joilla voidaan osaltaan pystyä edistämään 
verisuoniterveyttä ja toisaalta tarjota luonnollinen vaihtoehto elintarvikkeiden 
säilyvyyden parantajina. Samaan aikaan elintarviketeollisuudessa, mm. rypsi- 
ja perunateollisuudessa, muodostuu sivutuotteena suuria määriä 
proteiinipitoisia jakeita, joiden käyttöä voitaisiin tehostaa hyödyntämällä niitä 
bioaktiivisten peptidien raaka-aineena.  
Tämän työn tavoitteena oli tutkia mahdollisuutta tuottaa perunan ja rypsin 
proteiineista bioaktiivisia peptidejä, joilla on ACE esto aktiivisuutta ja 
antioksidatiivisia vaikutuksia. Peptidejä tuotettiin entsymaattisen hydrolyysin ja 
fermentoinnin avulla, tuotettujen peptidien ACE esto ja antioksidatiiviset 
vaikutukset määritettiin in vitro, aktiiviset peptidit konsentroitiin 
kalvosuodatuksella ja kiinteäfaasiuutolla, jonka jälkeen aktiivisimmat peptidit 
puhdistettiin nestekromatografisin menetelmin ja analysoitiin 
massaspektrometrisesti aktiivisten peptidisekvenssien tunnistamiseksi. Rypsistä 
tuotettujen ACE esto aktiivisten peptidien kykyä säilyä aktiivisessa muodossa 
ihmisen ruuansulatuksessa arvioitiin in vitro ruuansulatusmallin avulla 
käyttämällä ihmisestä eritettyjä ruuansulatusnesteitä ja rypsin 
peptidikonsentraatin kykyä ehkäistä verenpaineen nousua in vivo tutkittiin 
eläinmallissa ns. 2K1C rotilla.  
Tulokset osoittivat, että rypsi- ja perunaproteiineista voidaan entsymaattisen 
hydrolyysin avulla tuottaa peptidejä, joilla on tehokasta ACE esto ja 
antioksidatiivista aktiivisuutta. Fermentointikäsittelyillä tuotettujen peptidien 
aktiivisuudet olivat heikompia entsyymikäsittelyillä tuotettuihin verrattuna. 
Tulokset osoittivat myös, että perunan luontaiset entsyymit pystyvät tuottamaan 
perunan proteiineista ACE esto aktiivisia peptidejä ilman ulkopuolisen 
entsyymin lisäystä. Rypsin peptidikonsentraatti pystyi estämään verenpaineen 
nousua in vivo 2K1C rotilla, mutta peptidien valmistuksessa raaka-aineena 
käytetyn rypsirouheen laadulla todettiin olevan merkittävä vaikutus 
verenpainevaikutuksiin ja peptidifraktion koostumukseen. 
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1 INTRODUCTION 
Cardiovascular diseases (CVD) represent the main cause of death in the 
world. Over 17 million people globally are estimated to die from CVD every 
year, and in Europe these diseases are responsible for more than half of all 
deaths (World Health Organization, 2011). Primary prevention has an 
increasing importance as part of public health strategies to reduce societal 
burden due to CVD-related morbidity and mortality worldwide. The World 
Health Organization emphasizes the importance of improved nutrition as means 
of controlling the expected rise in global CVD incidence over the coming 
decades. 
The renin-angiotensin system (RAS) is a major regulator of blood pressure 
and fluid homeostasis; dysregulation of the RAS can lead to blood pressure 
elevation with ensuing cardiovascular disease, chronic kidney disease and 
diabetes. The regulatory mechanism takes place in the kidneys, where the 
hydrolytic enzyme renin is secreted. Renin cleaves plasma angiotensinogen to 
release the inactive decapeptide called Angiotensin I, which is subsequently 
hydrolyzed by Angiotensin Converting Enzyme (ACE: EC 3.4.15.1) to form 
Angiotensin II, which is a prohypertensive vasoconstrictor (Cheung et al., 
1980). ACE is a metallopeptidase membrane protein and it also degrades 
bradykinin, which regulates different physiological processes and excerts 
antihypertensive effects through the kinin-nitric oxide system. Therefore, ACE 
and renin are two key enzymes that regulate RAS operation and ACE inhibitors 
have been widely used as antihypertensive agents (Guang et al., 2012). 
Meanwhile, there is strong evidence that reactive oxygen species (ROS) 
generated from sequential reduction of oxygen during the normal respiration of 
aerobic organisms may cause cellular damage leading to a number of 
pathological conditions, including atherosclerosis, arthritis, diabetes, and 
carcinoma (Beckman and Ames, 1998). The natural endogenous enzymatic and 
non-enzymatic antioxidant system suppresses ROS in order to maintain the 
balance called redox homeostasis. An imbalance in the redox homeostasis leads 
to excessive levels of ROS and oxidative stress (Valko et al., 2007). Therefore, 
dietary antioxidants can supplement the antioxidant system and help to reduce 
the degenerative oxidative damage (Fang et al., 2002). On the other hand, 
oxidation is also a critical mechanism also in deterioration during food 
processing and storage. Synthetic food antioxidants have been widely applied 
in the food industry for food preservation, but the use of natural antioxidants as 
food preservatives is of increasing interest. For these reasons dietary 
antioxidant compounds, food-derived bioactive peptides among them, have 
gained a great attention.  
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The role of dietary compounds in the prevention of CVD is of increasing 
importance in tackling this major health problem. Increased protein 
consumption, particularly from plant sources, has been related to reduced blood 
pressure and prevention of CVD in recent observational and clinical studies. 
Meanwhile, interest has been emerging in identifying and characterizing 
bioactive peptides with cardiovascular health-enhancing properties. Bioactive 
peptides are considered specific protein fragments that are inactive within the 
sequence of the parent protein. After they are released they may exert various 
physiological functions, such as antihypertensive, antioxidant, opioid, 
immunomodulatory and antimicrobial effects (Pihlanto and Korhonen, 2003; 
Guang and Phillips, 2009). Most widely studied protein sources of bioactive 
peptides are of animal origin, such as milk proteins and egg (Pihlanto and 
Korhonen, 2003; Majumder and Wu, 2009), but plant protein sources have 
attracted increasing attention in the recent years. ACE inhibitory and 
antioxidative activities in vitro have been reported for several plant protein-
derived enzymatic hydrolysates, for example for rapeseed (Mäkinen et al., 
2012; He et al., 2013a), flaxseed (Marambe et al., 2011), mung bean (Li et al., 
2006) and potato (Pihlanto et al., 2008) protein-derived hydrolysates. Recently, 
antihypertensive effects in vivo of plant protein-derived hydrolysates have also 
been demonstrated. For example, sweet potato protein hydrolysate (Ishiguro et 
al., 2012) and rapeseed hydrolysate (Alashi et al., 2014) have been shown to 
possess antihypertensive effects in spontaneously hypertensive rats. 
Rapeseed (Brassica napus) is the third most important oilseed crop 
worldwide and also represents the world’s second leading source of protein 
meal (Fediol, 2014). The protein content of defatted rapeseed meal is high, 
approximately 32% (Klockeman et al., 1997), making it a potential food 
ingredient instead of being used as animal feed or wasted. The nutritive and 
functional properties of rapeseed are characterized by three main protein 
families: storage proteins cruciferin and napin, and oleosin, which is a 
structural protein associated with the oil fraction (Bos et al., 2007). Yet, there 
are only a few studies examining rapeseed meal as a source of bioactive 
peptides to enhance the value of this rapeseed industry by-product. These 
studies include the use of enzymatic hydrolysis to produce antihypertensive and 
antioxidative peptides from rapeseed (Marczak et al., 2003; He et al., 2013a; 
Alashi et al., 2014) and production of antithrombotic peptide fractions with 
Alcalase hydrolysis (Zhang et al., 2008). At the same time, potato is one of the 
main vegetables consumed in European and American diets, and the 
consumption is increasing strongly in Asia, Africa and Latin America. The 
content of protein in potato is around 3%; however the nutritional value of 
proteins is high. The production of starch from potatoes - 1.4 million tons in 
EU during the year 2012 - produces huge quantities of residual by-products: 
Introduction 
 
3
potato pulp consisting of remnants of the cell walls of potato tubers, including 
the skin and residual intact cells containing starch, and potato fruit liquid. The 
potato fruit liquid is characterized by a high content of proteins, free amino 
acids and salts, whereas the pulp fraction contains mainly starch, cellulose, 
hemicelluloses, pectin and fewer proteins (Kempf, 1980). Potato fruit liquid is 
primarily used as a source for enriching proteins and amino acids, and also as a 
fertilizer due to its high nitrogen content. However, the high quality protein 
component of the potato fruit liquid could be a potential source material of 
bioactive peptides for production of health promoting ingredients to enhance 
the value of this by-product.   
Review of the Literature 
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2 REVIEW OF THE LITERATURE 
2.1 Potato 
The potato has achieved worldwide prominence as a food item, in part, due 
to its tremendous yield per unit area compared to many other food crops. World 
potato growing areas are in a state of dynamic change. The production levels in 
the developed nations of Europe, North America, and the former Soviet Union 
have declined by 20 million metric tons (mmt) within the years 2003 and 2012. 
During the same interval, production has doubled in countries of the 
developing world including Asia, Africa and Latin America. More than a 
billion people globally eat potato and total potato production exceeds 300 
million metric tons worldwide. Almost half of the global potato supply is now 
consumed in Asia (FAO, 2008). Potato increasingly contributes to world 
security and has a critical role to play in developing countries facing hunger. 
Potatoes supplement or replace grain-based diets where rice, wheat or corn 
availability has lessened or price has become unaffordable. The potato now 
ranks third, behind rice and wheat for human food as the use of corn for 
biofuels and animal feeds has lessened its human food applications. Considered 
from environmental aspects, potatoes produce more food per unit of water than 
any other major crops. In comparison to cereals, potatoes produce greater dry 
matter and protein per unit of growing area (FAO, 2014). 
2.1.1 Characteristics of potato tuber 
The potato is a common staple food and is available in many forms. The 
protein content of potato is around 3%; however the nutritional value of these 
proteins is high and in the dry matter the protein content is about 10% which is 
at the same level as most cereals, including rice and wheat (Friedman, 1996). 
Potato tuber proteins are classified into three major groups: patatins, protease 
inhibitors, and other proteins (Pots et al., 1999). Patatin is the major storage 
protein in potato tubers and also an allergen for some people. This allergenicity 
is significantly reduced by heating. The second major potato tuber storage 
protein is a diverse group of low molecular-weight protease inhibitors. The 
patatins and protease inhibitors comprise about 40% of the total potato tuber 
protein. The majority of the patatin and proteinase inhibitor isoforms also 
possess enzymatic and inhibitory activities, respectively, which might be of 
physiological relevance. A summary of the nutritive value of potato protein 
was produced in 1975 by Markakis and it showed that the amino acid 
composition is nutritionally comparable to whole egg protein; the calculated 
protein quality is about 70% that of whole egg protein. The lysine content of 
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potatoes is excellent, but they contain fewer sulfur amino acids that limit the 
nutritive value. On the other hand, human feeding trials have suggested that the 
nutritional quality of potato proteins may be higher than the amino acid 
composition indicates. It needs to be taken into account that about 50% of the 
total nitrogen of potato is derived from free amino acids and amide nitrogen of 
asparagine and glutamine (38%) as well as nonprotein nitrogen associated with 
glycoalkaloids and secondary metabolites (12%) and these components may 
enhance the utilization of proteins (Markakis, 1975). When the nutritional 
quality of potato concentrate was measured in terms of biological value (BV), 
net protein utilization (NPU), nitrogen retention and protein efficacy ratio 
(PER), the nutritional quality was found to be very high with a PER-value of 
2.90. PER-value was measured as a weight gain of a test group/total protein 
consumed (Nestares et al., 1993). An earlier human trial by Kies and Fox (1972) 
showed that the physiological nitrogen balance increased when the potato 
protein was supplemented with methionine (0.3%). Recently Bartova and Barta 
(2009) isolated protein concentrates from industrial potato juice and measured 
the nutritional value. The protein concentrates exhibited high nutritional value 
as the essential amino acid index was over 80%. 
Potato is also an important source of vitamins and minerals, such as calcium, 
potassium, phosphorus and ascorbic acid. Studies have indicated that potato 
tubers contain phenolic compounds, for example chlorogenic acid, which have 
been shown to possess free radical scavenging activity in vitro (Friedman, 
1996). Due to the large amounts consumed, they may be a significant source of 
health-promoting phenolic compounds. The nutrient content of potatoes is 
favourable; therefore, using potatoes moderately as a part of a meal should be 
encouraged. A medium-size 150 g potato with the skin provides 27 mg of 
vitamin C (45% of the daily value (DV)), 620 mg of potassium (18% of DV), 
0.2 mg of vitamin B6 (10% of DV) and trace amounts of thiamin, riboflavin, 
folate, niacin, magnesium, phosphorus, iron, and zinc (Camire  et al., 2009). 
Potatoes contain toxic compounds known as glykoalkaloids, of which the most 
prevalent are solanine and chaconine. Exposure to light, physical damage and 
age increase glykoalkaloid content within the tuber. Although glykoalkaloids 
are perceived as potentially toxic, studies during the past 10 years suggest that 
they may also possess beneficial effects, depending on dose and conditions of 
use (Friedman, 2006).  
In the current literature, only rather scattered information concerning the 
potato proteome is available. Most of the data is related to the resistance of 
potato plants to pathogens, and the regulation of pathogenesis-related and 
stress-responsive proteins in potato (Lim et al., 2013). Studies have 
consistently shown that the developmental stage and physiological age of 
potato tubers are associated with significant alterations in the protein 
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composition of tubers. This fact is presumably a notable factor for the 
production of bioactive peptides (Mäkinen et al., 2008). Lehesranta et al. (2006) 
and DelaPlace et al. (2009) observed significant changes in the potato tuber 
proteome during tuber development and physiological age and qualitative and 
quantitative changes have been detected in protein content during the 
development of tubers (Borgmann  et al., 1994), dormancy (Espen et al., 1999) 
and after dormancy (Desires et al., 1995a; Desires et al., 1995b). The 
differentiation in the potato protein isoforms and protein expression levels 
between the potato cultivars has recently been linked to techno-functional 
properties of potato, such as the tuber’s susceptibility to bruising upon 
mechanical impact (e.g. an enzymatic browning reaction) (Urbany et al., 2012) 
and to the cold-induced sweetening (Fischer et al., 2013; Folgado et al., 2014). 
Differentiations between patatin and lipoxygenase isoforms have been 
suggested to play an important role in these aspects. Moreover, patatins have 
been reported to possess enzymatic activities, in particular, broad 
phospholipase activity has been characterized and documented (Bauw et al., 
2006; Scherer et al., 2010). The lipid acyl hydrolase activity of patatins has 
also been detected in industrial potato fruit juice and this enzyme activity may 
be utilizable even after concentration of proteins by precipitation (Bartova and 
Barta, 2009). The patatin group consists of a number of glycoprotein isoforms 
that differ between potato cultivars as well as in physiological state (DelaPlace 
et al., 2009; Hoehenwarter et al., 2011). A high degree of homology between 
the patatin isoforms has been observed by N-terminal amino acid sequence 
analysis (Shewry, 2003). Protease inhibitors are a diverse group of proteins that 
differ widely in their amino acid sequence (Heibges et al., 2003). The protease 
inhibitors have various physiological activities associated with the defense 
mechanisms of potato against pathogens and they inhibit a variety of proteases 
and furthermore, also some other enzymes, for example invertase (Heibges et 
al., 2003). 
Studies have reported that potatoes are one of the most glycaemic and 
insulinogenic foods. However, in most meals, potatoes are accompanied by 
other foods and glycaemic and insulinaemic responses are modified when 
ingested as part of a mixed meal: the co-ingestion of fat and protein reduced the 
glycaemic responses and the co-ingestion of protein increased the insulinaemic 
responses in subjects with type 2 diabetes (Gulliford et al., 1989). A recent 
study investigated how glycaemic and insulinaemic responses to a mashed 
potato meal changed when a high-fat food (rapeseed oil), a high-protein food 
(chicken breast) and/or salad were added to the meal. The results indicated the 
protein, fat and salad contents of a meal exert considerable influence on the 
glycaemic and insulinaemic responses to mashed potatoes (Hätönen et al., 
2011). 
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In summary, the results indicate potential for potato protein to be utilized in 
food formulations with enhanced protein quality. It would be useful to combine 
diets consisting of potatoes (high in lysine and low in sulfur amino acids) with 
cereals (high in sulfur amino acids and low in lysine) to achieve a well-
balanced protein composition. As potatoes have to be processed before eating 
it’s important to notice, that the losses in the nutritive value of potato protein 
during boiling and frying are minor (Friedman, 1997), whereas canning and 
chipping cause remarkable losses (Jaswal, 1973). 
2.1.2 Potato starch production 
Over the last 20 years there has been a threefold worldwide increase in 
starch production and in the EU the production figures have increased by 2.5. 
In the year 2012 the worldwide starch production totalled 75 million tons of 
which the production in the EU was 10 million tons. Potato is the third most 
important raw material for industrial starch production after maize and wheat; 
potato accounts for 33% of raw material within the EU (Figure 1) (AAF 
European Starch Industry Association, 2014). In particular, potatoes are a 
fundamental European crop for starch and it is extremely important to keep 
potato starch competitive with maize starch made from imported maize. 
 
 
Figure 1 Raw materials used for starch production in the EU 2012 (AAF 
European Starch Industry Association, 2014) 
 
The production of starch from potatoes - 1.4 million tons in EU 2012 - 
produces huge quantities of residual by-products (AAF European Starch 
Industry Association, 2014): particulate fraction called potato pulp and the 
potato fruit liquid characterized by high protein content (Kempf, 1980). The 
current use of potato fruit liquid for enriching proteins and for fertilization 
could be enhanced by utilizing the proteins as potential raw material for value-
added ingredients such as bioactive peptides. Potato pulp is applied as cattle 
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feed, in an enzymatically treated and condensed form as syrup for crisps and 
chips and as a substrate for the cultivation of fungi that may be used for 
degradation of soil contaminants and in addition, for the production of 
cosmetics. 
2.1.3 Potential health-promoting properties of potato proteins and 
peptides 
2.1.3.1 Prevention of cardiovascular diseases 
Although many factors affect the status of the heart and circulatory system, 
maintenance of normal serum lipids and blood pressure is essential for health. 
Potato contains several compounds beneficial to cardiovascular health. The 
lipid content is low (0.10 g/100 g FW), and dietary fiber is especially found in 
peels. With regard to the mineral composition, relatively high potassium levels 
are needed to counteract the effect of sodium and protect against hypertension. 
Reactive oxygen species are shown to be the key modulating factors 
responsible for the development of many age-related disease conditions 
including cardiovascular diseases. Inflammation is another risk factor for 
cardiovascular disease. Although many biomarkers for inflammation exist, 
high-sensitivity C-reactive protein (CRP) has received most attention as a 
predictor for cardiovascular disease. Potatoes contain a diverse mixture of 
antioxidants - mainly phenolic compounds but also peptides - which exhibit 
multiple antioxidant activities in vitro and antioxidant effect of potato peel 
extract has been demonstrated also in rats (Singh et al., 2008). Results from 
clinical trials have indicated that phenolic compounds of potato tubers may also 
lower inflammation (Kaspar et al., 2011). In addition, peptides can inhibit the 
Angiotensin I-converting enzyme (ACE) which is one of the key factors in the 
control of blood pressure. The ACE inhibitory and antioxidant effects of potato 
peptides have been shown in vitro and the effects in vivo remain to be 
investigated. The antioxidant and ACE inhibitory activities of potato proteins 
and peptides are summarized in Table 1. The ACE inhibition activities are 
expressed as protein concentrations needed to inhibit 50% of the activity of 
ACE (IC50 mg protein/ml), and antioxidant activities are represented as Trolox 
equiivalents and inhibition percentages describing the efficacy of samples for 
reducing the formation of oxidation products in lipid oxidation. 
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Cheng et al. (2010a and 2010b) recently identified several low molecular-
weight antioxidative peptides from the Alcalase hydrolysate of potato protein. 
The peptides enhanced the oxidative stability of soybean oil in water emulsion 
and possessed radical scavenging activity in vitro against ABTS-radical. 
Peptides consisting predominantly of hydrophobic amino acid residues are 
known to exert high radical scavenging activity. The results indicated that the 
protective effect of potato peptides against lipid oxidation is probably due to 
other reaction mechanisms than radical scavenging as the hydrophobicity of 
peptides was not the dominating factor of the protective effects. In fact, the 
results indicated that the partitioning of the peptides on the membrane would 
have a critical role in the protection against oxidation (Cheng et al., 2010a; 
Cheng et al., 2010b). The results of Elias et al. (2008) support the partitioning 
theory as they reported that the partitioning of less polar peptides in the 
membrane is more extensive and this provides a stronger protection of fat 
globules from free radical and peroxidant attack. Liu et al. (2003) found that 
purified patatin exerts antioxidant or antiradical activity in in vitro tests, such as 
DPPH radical and hydroxyl radical scavenging activity, and protection against 
hydroxyl radical-induced calf thymus DNA damage. DelaPlace et al. (2009) 
studied the changes in the potato tuber antioxidant system during the post-
harvest ageing of the tubers and found out that the changes in the proteome 
allowed potato tubers to maintain their radical scavenging activity until the end 
of the rather long storage period (+4 °C 270 d). Studies by Singh et al. (2008) 
indicated that potato peel extract treatment had a potent protective effect 
against oxidative stress and acute liver damage induced by CCl4 in rats, as 
revealed by a remarkable decrease in hepatic MDA content accompanied by 
enhanced GSH and SOD activities. Human studies in healthy men showed that 
consumption of pigmented potatoes (150 g/day) lowered plasma IL-6 and DNA 
damaged compared to white potatoes. Moreover, the purple flesh potato group 
tended to have lower plasma C-reactive protein concentration than the white 
potato group (Kaspar et al., 2011). 
Hydrolysis of protein isolates from potato tubers has also been found to 
enhance ACE inhibition (Table 1: Pihlanto et al., 2008). In further studies it 
was shown that autolysis with native potato proteases also enhanced ACE 
inhibition capacity (Mäkinen et al., 2008). The physiological age of the tubers 
had a significant effect on the production of ACE inhibition during the 
autolysis, the rate of ACE inhibition formation and the tuber tissue where ACE 
inhibition was most pronounced. Differences in enzymatic activities were 
confined to different parts of the potato tuber at different physiological stages. 
Many of the tuber proteins were seen to degrade during the autolysis including 
two aspartic protease inhibitors which were degraded in the highest 
concentrations. Enrichment of recombinant potato tuber protein to the autolysis 
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enhanced the production of activity significantly, which suggests the possibility 
of enhancing potato tuber ACE inhibitory potential by means of 
biotechnological tools (Mäkinen et al., 2008). According to the current 
literature summarized in Table 1, Alcalase would be the most effective enzyme 
for the production of ACE inhibitory and antioxidative peptides from potato 
proteins (Pihlanto et al., 2008; Cheng et al., 2010a; Cheng et al., 2010b). 
Moreover, results indicate that the peptide sequences of ACE inhibitory and 
antioxidative peptides are different as the ACE inhibitory peptides are rich in 
alanine (Pihlanto et al., 2008) whereas antioxidative peptides contain very few 
alanine residues (Cheng et al., 2010a; Cheng et al., 2010b). In any case, it has 
to be underlined that rather few potato peptides or peptide fractions with 
antioxidant or ACE inhibitory properties have been characterized thus far and 
more research is needed to characterize and identify the ACE inhibitory potato 
peptides and to evaluate the in vivo antihypertensive and antioxidant potential. 
 
2.1.3.2 Antimicrobial and antifungal properties 
Antimicrobial peptides are a group of peptides that have a broad activity 
against a diverse group of microorganisms. Due to their action mechanisms 
these peptides are potential molecules that could help to overcome the 
problems of the increasing resistance of bacteria to conventional antibiotics. 
Antimicrobial proteins/peptides in plants have a major role in the innate host 
defense mechanisms. Innate immunity is an ancient defense system of 
multicellular organisms to control natural flora and combat pathogens. 
Antimicrobial peptides have been detected in a wide variety of plants and their 
potent in vitro antimicrobial activity indicates that they may play a general 
protective role against pathogens. These peptides act through various 
mechanisms, eg. altering cell membrane permeability and liposome interactions 
(Garcia-Olmedo et al., 1998), but many of the mechanisms are not clear thus 
far.  
Several antibiotic peptides/proteins have been purified from potato. These 
peptides and proteins isolated from potato tubers have been classified into three 
classes: globulins, defensins and protease inhibitors. The globulins include the 
major proteins/peptides, patatins, in potato tubers. Patatins have been reported 
recently to possess phospholipase activity on phospholipid and 
lysophospholipid substrates and also esterase activity. Patatin have also been 
found to have hydrolytic activity as an acidic β-1,3-glucanase. This glucanase 
is involved in the pathogenesis-related protein response (Van Loon et al., 1999). 
Defensins were isolated during the extraction of the insoluble proteins of potato 
tubers and they include, for example, the antifungal peptides Pseudothionin 
Solanum tuberosum (Pth-St1) (Moreno et al., 1994), snaking-1 and snaking-2 
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(Segura et al., 1999; Berroca-Lobo et al., 2002). The snaking/GASA 
(gibberellic acid-stimulated Arabidopsis) family peptides are basic and rich in 
Cys residues and possess almost identical antibacterial activity with 
aggregation of bacteria (Berroca-Lobo et al., 2002). The third class of 
antibiotic peptides/proteins of potato, protease inhibitors, also plays an 
important role in the defense mechanism of plants. Several peptides with 
antibiotic properties have been purified and identified as being homologous 
with protease inhibitors (Feng et al., 2003). 
Many of the isolated antimicrobial peptides of potato that are supposed to be 
antibiotic against bacterial and fungal pathogens of potato (such as Clavibacter 
michiganensis subspecies and Fusarium solani) have not been tested against 
human pathogens. However, a few rather low molecular-weight antimicrobial 
potato peptides belonging to the protease inhibitor Kuniz family have also 
recently been reported to exhibit antibimicrobial activity against human 
pathogenic fungal and microbial strains (Table 2). Kim et al. (2006) isolated a 
small, 5 578.9 Da, antimicrobial peptide from a water-soluble protein fraction 
of potato tubers (Solanum tuberosum L cv. Golden valley). This peptide, 
Potide-G, was found to inhibit the growth of a variety of bacterial 
(Staphylococcus aureus, Listeria monocytogenes, Escherichia coli and 
Clavibacter michiganense subsp. michiganinse) and fungal (Candida albicans 
and Rhizoctonia solani) strains. Potide-G was reported to be heat stable and 
suppress the proteolytic activity of trypsin, chymotrypsin and papain. Potamin-
1 peptide, 5 600.4 Da, a trypsin-chymotrypsin protease inhibitor was also 
isolated from the water-soluble fraction of potato tubers (Solanum tuberosum L 
cv. Gogu) (Kim et al., 2005). Potamin-1 inhibited several pathogenic microbial 
and fungal strains of which Candida albicans is the most common cause of oral, 
esophageal, vaginal and urinary candidiasis in humans (Kim et al., 2005). Also 
an antifungal protein, AFP-J, has been purified from potato tubers (Solanum 
tuberosum L cv. Jopung) (Park et al., 2005). This peptide, AFP-J, 13 500.5 Da, 
is produced in potato upon fungal attack (Kim et al., 2005) and was shown to 
exhibit effective antifungal activity against several human pathogenic fungi 
(Candida albicans, Trichosporon beigelii and Saccharomyces cerevisiae). 
Recently, the AFP-J peptide was characterized further and a novel 
antimicrobial peptide against Candida albicans was identified as Ala-Val-Cys-
Glu-Asn-Asp-Leu-Asn-Cys-Cys with MW of 1 083.1 Da (Lee et al., 2012). 
Moreover, Jin et al. (2009) discovered that refined potato protein was able to 
reduce the total bacteria, coliforms and Staphylococcus spp in the feces and 
contents of the colon and rectum in weanling pigs.  
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Table 2 Antibiotic activities of potato peptides against human pathogens 
Inihibited microbial 
strain  Minimal inhibition concentration (µg/mL)  
  Potide-Ga  AFP-Jb Potamin- 1c  Potide-Jd 
T. beigilii  ND  6.25 - - 
C. albicans  <30  6.25 100 µM  6.25 
S. cerevisiae  <30  6.25 - - 
aKim et al., 2006; bPark et al., 2005; cKim et al., 2005; dLee et al., 2012 
2.1.3.3 Satiety-promoting properties, antitumor effects and some 
other potential health-promoting properties of potato 
proteins/peptides 
Obesity-related health problems are generally known to be a rapidly 
escalating issue globally. Diet and lifestyle are important factors in the 
prevention and treatment of obesity and obesity-related diseases. The current 
literature includes indications that potatoes may have a role in controlling 
appetite and therefore weight gain, by contributing to satiety (Foltz et al., 2008; 
Nakajima et al., 2011). The satiety-promoting and other bioactivities reported 
in the literature for potato proteins and hydrolysates are summarized in Table 3. 
Gastrointestinal hormones such as cholecystokinin (CCK) are key factors in the 
regulation of food intake and maintaining energy homeostasis (Cummings and 
Overduin, 2007). CCK is known to be a major endocrine determinant in food 
intake regulation and proteins have been reported to be the most satiating of all 
macronutrients (Cummings and Overduin, 2007). Studies in animals and 
humans using different protein sources suggest that in order to stimulate CCK 
secretion efficiently, the protein needs to be hydrolyzed to short-chain peptides 
and amino acids through processing or gastrointestinal degradation (Schwartz, 
2000). As obesity is a major global health problem the prevalence of which is 
increasing alarmingly, discovering functional food products for weight 
management purposes is of a great interest. Either specific protein hydrolysates 
or other food-grade bioactive compounds with optimized CCK-releasing 
properties are potential target molecules for this purpose. Protease inhibitors 
with a variety of physiological roles comprise about 40% of potato tuber 
proteins (Pots et al., 1999). Hill et al. (1990) reported reduced energy intake 
and increased CCK release, when protease inhibitors extracted from potatoes 
were tested in 11 lean subjects. More recent results have reinforced the 
potential of potato peptides as satiety-promoting agents as potato protein 
hydrolysate was found to induce CCK release and stimulate CCK1R expression 
in enteroendocrine cells (Foltz et al., 2008). Potato protein extract has also been 
found to suppress food intake dose dependently in rats after oral administration 
(Nakajima et al., 2011). Also in this study, the results indicated that food intake 
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suppression was controlled through the induced CCK secretion and inhibition 
of luminal trypsin. However, Peters et al. (2011) found that potato protease 
inhibitors in a minidrink at a dose of 30 mg, as commercially used, had no 
effect on a range of behavioral and physiological appetite and intake control 
measures in humans.  
The incidence of diabetes is increasing enormously throughout the world and 
type -2 diabetes involves 90% of diabetics. Diabetes is often associated with 
obesity and dyslipidemia and the development of diabetes and its progressive 
complications is characterized by hyperglycemia meaning unregulated elevated 
blood sugar levels (Hätönen et al., 2011). Hyperglycemia induces oxidative 
stress; biomarkers of free radical-induced damage are increased and antioxidant 
defenses are reduced. The role of potato in the prevention of diabetes is 
complicated due to the high content of carbohydrates and on the other hand, 
antidiabetic factors such as antioxidants. Potato peel extracts, which contain a 
rich content of phenolic antioxidants have been demonstrated to reduce 
hyperglycemia, oxidative stress and overall food consumption in diabetic 
rodents (Singh et al., 2005). The observed effects are presumably mainly due to 
the phenolic compounds and the potential effects of potato proteins/peptides on 
these issues remains to be investigated. 
 
Table 3 Other bioactive properties of potato proteins and peptides 
Sample Outcome 
Potato protein preparatea Cholesterol-lowering effects in rats 
Potato peptide fractionb LDL-lowering, HDL-increasing and fecal neutral 
steroid excretion properties 
Potato protease inhibitor 
extractc 
Reduced energy intake and increased CCK release in 
human subjects 
Potato protein extractd Suppressed food intake in rats 
Potato serine and 
carboxypeptidase 
inhibitorse; f; g 
Tumor cell growth inhibition 
aMorita et al., 1997; bLiyanage et al., 2008; cFoltz et al., 2008; dNakajima et al., 
2011; eBlanco-Aparicio et al., 1998; fKennedy, 1998a; gHuang et al., 1997 
The role of vegetable consumption in the prevention of cancer has not 
reached consensus in the scientific community. Protease inhibitors have 
received new interest as they have been shown to have potent ability to prevent 
carcinogenesis in various in vivo and in vitro systems (Kennedy, 1998a; 
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Kennedy, 1998b). Tumor cell growth has also been reported to be inhibited by 
serine protease inhibitors and carboxypeptidase inhibitors of potato (Huang, et 
al., 1997; Blanco-Aparicio et al., 1998; Kennedy, 1998a). The antitumor 
properties related to potato proteins are summarized in Table 2. Anticancer 
effects of purified sweet potato protein on human colorectal cancer cells have 
also been shown (Li et al., 2013). The role of phenolic compounds of potato in 
cancer prevention also needs to be taken into account. Potato tuber extracts and 
the anthocyanin fraction has been reported to reduce cell growth and induce 
apoptosis in prostate cancer cell lines (Reddivari et al., 2007). Likewise, intake 
of anthocyanins from purple and red potatoes might play a protective role 
against stomach cancer (Hayashi et al., 2006). Isolated anthocyanins induced 
apoptosis in human cancer cell lines as well as suppressing mouse stomach 
cancer proliferation, indicating that anthocyanins were bioactive antitumor 
components. Potato glykoalkaloids inhibited the growth of human colon and 
liver cancer cells (Lee et al., 2004). In summary, the published data regarding 
the cancer-related health effects of potato in the diets of consumers is limited; 
however, cell line studies indicate potato protease inhibitors and phenolic 
compounds as antitumor agents.  
2.2 Rapeseed 
Rapeseed (Brassica napus) is grown mainly as a raw material for oil 
production. Rapeseed is related to mustard, cabbage, broccoli, cauliflower and 
turnip. Rapeseed is the third most important oilseed crop worldwide after 
sunflower and palm, and it represents the world’s second leading source of 
protein meal after soybean meal (Fediol, 2014). Global rapeseed production has 
grown rapidly over the past 40 years, rising from the sixth largest oil crop to 
the second largest. Rapeseed production represented 10 - 15 percent of the 
world oil crop production between years 2000 and 2009. During the last decade, 
European rapeseed production increased sharply from 12 million tons in 2000 
to 20 million tons in 2010 (FAOSTAT, 2014), mainly due to higher demands 
for biofuel.  
Usage of the terms rapeseed and canola is sometimes confusing, and thus, 
needs to be noted briefly. Canola seeds, which are mainly produced in Canada, 
Australia and the US, represent double 00-spring varieties such as Brassica 
napus L., Brassica campestris L. and Brassica Rapa var., and are characterized 
by low levels of erucic acid (<20 g/kg in the oil fraction) and low levels of 
glucosinolates (<30 μmol/g in toasted oil-free meal; Canola Council of Canada, 
2014). In comparison, contents of erucic acid and total glucosinolates in double 
00-winter rapeseed varieties grown in Europe must not exceed 20 g/kg in the 
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oil fraction and 27 μmol/g dry matter (DM) in the rapeseed (European Food 
Safety Authority, 2008), respectively.  
The small, round rapeseed seed contains 38 to 45 percent oil. In addition to 
high oil content, rapeseed seeds contain approximately 17 - 26% protein 
(Uppstrom, 1995). In the food sector the importance of rapeseed is mainly 
related to oil composition; it contains both omega-6 and omega-3 fatty acids in 
a ratio of 2:1. Due to the high protein content in the seeds the presence of traces 
of protein in the final oil is extremely difficult to prevent. It is well recognized 
that the role of proteins in the allergenicity of edible oils is a growing problem. 
Among all edible oil sources, it has been reported that olive and 
rapeseed/canola are nonallergenic (Hidalgo and Zamora, 2006). 
2.2.1 Production of milled rapeseed 
Rapeseed seeds are crushed at processing facilities into oil and meal. They 
are first pressed to extract the bulk of the oil, and afterward, most crushing 
facilities add a chemical solvent to remove the remaining oil. The supplies of 
canola meal and oil are linked through the crushing process even though 
demand for these products is independent. Rapeseed oil production increased 
globally by 10 million tons between the years 2000 and 2010 (Fediol, 2014). 
The majority of the global rapeseed oil supply is produced in the EU, China, 
Canada and India. In EU countries the annual production is estimated to reach 
10 million tons in 2014 (USDA, 2014). Rapeseed meal is generated as a by-
product of industrial oil extraction and has been widely used as a protein 
supplement in the formulation of livestock feed (Aidera and Barbanab, 2011). 
In 2012, global canola meal production was 33.8 million metric tons (Carré and 
Pouxet, 2014). Rapeseed meal is primarily used as protein-rich feed ingredient 
for livestock due to its relatively high content of indispensable amino acids, 
particularly sulphur amino acids, in comparison to other protein ingredients, 
including soybean meal (Mansour et al., 1993; Woyengo et al., 2010; USDA, 
2012). However, high protein content makes it a potential food ingredient 
instead of being used as animal feed or wasted. 
2.2.1.1 Characterisrics of rapeseed meal 
Rapeseed meal contains up to 50% protein on a dry basis (USDA, 2012). 
The amino acid compositions of the rapeseed protein isolates have been studied 
and reported by several researchers and the results indicate that the amino acid 
composition is altered depending on the industrial oil extraction process, and 
particularly depends on the process used for protein extraction from the 
rapeseed meal residue. Usually, up to 30% of the total protein initially present 
in rapeseed meal is extracted in an alkaline medium, and large-scale 
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purification of rapeseed proteins significantly affects the final protein 
composition (Chabanon et al., 2007).  
The use of rapeseed meal in diets for monogastric animals such as pigs is 
often limited due to its high fiber content (Grala et al., 1998; Mailer et al., 2008) 
and the presence of several antinutritional factors, including different 
glucosinolates, phenolic compounds and phytates (de Lange et al., 1998). 
These compounds are responsible for the toxic, antinutritional and undesirable 
coloration capacity of canola proteins. In particular, free and esterified phenolic 
acids have been reported to cause the undesirable taste of rapeseed products 
(Naczk et al., 1998). Condensed tannins are also found in rapeseed meal 
residue and proteins extracted from it (Clandinin and Heard, 1968; Shahidi and 
Naczk, 1989). Proteins may interact with flavoring compounds such as 
phenolics and these interactions can influence the flavor properties (Hagerman 
and Butler, 1981; Shahidi and Naczk, 1995; Naczk et al., 1998). Another 
limiting factor is the rather high content, up to 4%, of phytates in rapeseed 
proteins (Naczk et al., 1986). Phytates are antinutritional compounds reducing 
the bioavailability of divalent cations such as Ca, Mg, Zn, Cu and Fe and 
inhibiting the digestion of starch. On the other hand, phytates at low 
concentrations, may possess antioxidative and anticarcinogenic effects 
(Rickard and Thompson, 1997). Canola meal also contains indigestible fibers 
that are, however, diminished after protein extraction (Lacki and Duvnjak, 
1998). The glucosinolates can be eliminated to a certain extent for example, 
through hydrothermal treatment (Grala et al., 1998). In particular, the 
composition of rapeseed has been significantly improved by developing low 
glucosinolate and low erucic acid rapeseed cultivars.  
The underutilized protein component of rapeseed has potential properties for 
human nutrition that remain to be explored. The nutritional and functional 
properties of rapeseed protein are characterized by the major protein 
constituents of rapeseed meal: the storage proteins napin and cruciferin, and 
oleosin, which is a structural protein associated with the oil fraction (Uppstrom, 
1995). Rapeseed protein is a potential ingredient for use in the food industry as 
many characteristics of rapeseed protein are favorable for human nutrition. 
Rapeseed protein has recently been demonstrated to be of high nutritional value 
in human subjects (Bos et al., 2007). The amino acid composition of rapeseed 
meal is well balanced (Ohlson and Anjou, 1979; Mariscal-Landin et al., 2008) 
and the protein efficiency ratio of rapeseed meal is rather high, at 2.64, in 
comparison for example to soybean, at 2.19 (Delisle et al., 1984). Rapeseed 
proteins have shown interesting and promising functional properties and could 
be potentially used in various food matrices (Khattab and Arntfield, 2009; Xu 
and Diosady, 1994a and 1994b). The fat absorption, emulsifying activity and 
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foaming properties of rapeseed protein concentrates were superior in 
comparison to soybean protein (Ghodsvali et al., 2005).  
Efforts are focusing on developing canola protein products for food 
applications. Recently, the European Food Safety Authority has regarded 
rapeseed protein isolate as a safe novel food ingredient (European Food Safety 
Authority, 2013). Also, canola protein isolate and hydrolysate have received 
GRAS (Generally recognized as safe) notification in the USA by the Center for 
Food Safety and Applied Nutrition (U.S. Food and Drug Administration, 2011). 
2.2.2 Rapeseed as a source of bioactive peptides 
The increase in consumer awareness about healthy foods has encouraged 
researchers to identify bioactive natural components in different products 
(Murty et al., 2010). Rapeseed protein is suggested to be an attractive source of 
bioactive compounds. Recently, various different methods have been utilized to 
produce active peptides from rapeseed proteins. Most of the studies concern 
ACE inhibitory and antioxidant activity in vitro and antihypertensive effects in 
animal studies, but also other activities such as antithrombotic activity and cell 
growth effects have been demonstrated as bioactive characteristics of rapeseed 
proteins. The bioactive properties of rapeseed and canola protein-derived 
hydrolysates and peptides are summarized in Table 4 and Table 5. 
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2.2.2.1 Prevention of cardiovascular diseases 
2.2.2.1.1 Hypotensive properties 
Rapeseed meal as a source of bioactive peptides with ACE inhibitory 
properties has received increasing attention in the recent years. Most of the 
studies concern the utilization of various proteolytic enzymes to liberate ACE 
inhibitory rapeseed peptides (Marczak et al., 2003; Mäkinen et al., 2012; He et 
al., 2013c; He et al., 2013a; He et al., 2013b; Alashi et al., 2014), but also 
fermentation with lactic acid bacteria has been shown to release in vitro ACE 
inhibitory peptides from rapeseed (Pihlanto et al., 2012). Enzymatic 
hydrolysates of rapeseed meal and protein extracts have shown high ACE 
inhibitory potencies in vitro; the most active hydrolysates have been produced 
by Alcalase with 50% ACE inhibition concentrations of 15 µg protein/mL (Wu 
et al., 2008) and 20 µg protein/mL (Mäkinen et al., 2012). Wu and co-workers 
utilized consecutive hydrolysis with Alcalase and ENZECO Alkaline Protease 
L-FG resulting in a 50% ACE inhibitory value of 18 µg protein/mL (Wu et al., 
2008). Also, He and co-workers have reported high ACE inhibitory capacities 
in vitro for rapeseed meal hydrolysates and found Alcalase (~ 80% inhibition 
with 1 mg protein/mL) and Thermolysin (~ 85% inhibition with 1mg 
protein/mL) to be the most effective enzymes (He et al., 2013a). Rapeseed 
protein hydrolysates have also been shown to possess inhibitory capacity 
against renin, the other key enzyme in the regulation of blood pressure through 
the RAS system. In particular, the rapeseed protein Alcalase hydrolysate and 
Pancreatin hydrolysate have been reported to possess high renin inhibitory 
capacity in vitro, over 80% and 63%, respectively, with a protein concentration 
of 1 mg/mL (He et al., 2013a; Alashi et al., 2014). Rapeseed protein Subtilisin 
digest and Alcalase digest have been subjected to simulated gastrointestinal 
digestion in vitro in order to elucidate the ability of ACE inhibitory peptides 
present in these digests to resist gastrointestinal digestion and the possibilities 
of reaching the site for absorption (Marczak et al., 2003; Mäkinen et al., 2012). 
The Alcalase hydrolysate was treated with human gastric juices in laboratory 
conditions simulating human gastric and duodenal digestion, and the ACE 
inhibitory activity was retained at the same level through the digestion 
treatment, indicating that ACE inhibitory peptides present in the Alcalase 
digest are relatively resistant (Mäkinen et al., 2012). The Subtilisin digest was 
subjected to hydrolysis with different proteases to simulate gastrointestinal 
digestion in vitro, and the ACE inhibitory activity was changed only slightly, 
indicating that ACE inhibitory peptides present in the Subtilisin digest possess 
a relatively high ability to resist further hydrolysis into inactive degradation 
products (Marczak et al., 2003). 
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Relatively few ACE inhibitory peptides have been identified thus far and all 
of the identified peptides have been produced by enzymatic hydrolysis either 
with Subtilisin or Alcalase. Four ACE inhibitory peptides were isolated from 
the rapeseed Subtilisin digest: Arg-Ile-Tyr (IC50, 0.028 mM), Ile-Tyr (IC50, 
0.037 mM), Val-Trp (IC50, 0.0016 mM) and Val-Trp-Ile-Ser (IC50, 30mM) 
(Marczak et al., 2003). Peptides Ile-Tyr and Arg-Ile-Tyr can be found in the 
primary structure of napin and Val-Trp and Val-Trp-Ile-Ser exist in the primary 
structure of cruciferin and ribosomal protein, respectively. Altogether five 
peptide sequences with high ACE inhibitory capacity have been identified from 
rapeseed meal hydrolyzed with Alcalase: Val-Ser-Val (IC50, 0.15 µM), Phe-
Leu (IC50, 1.33 µM), Leu-Tyr (IC50, 0.11 mM), Thr-Phe (IC50, 0.81 mM) and 
Arg-Ala-Leu-Pro (IC50, 0.97 mM). These peptides are located in the primary 
structure of rapeseed napin and cruciferin proteins (Wu et al., 2008). In this 
study, the peptides Leu-Tyr, Thr-Phe and Arg-Ala-Leu-Pro were shown to 
possess dual inhibition potential against both ACE and renin activity. In 
contrast to ACE inhibitory activity, peptide sequence Arg-Ala-Leu-Pro (IC50, 
0.97 mM) was reported to possess the highest capacity against renin activity in 
comparison to Leu-Tyr (IC50, 1.87 mM) and Thr-Phe (IC50, 3.1 mM). A novel 
ACE inhibitory peptide Gly-His-Ser was identified from the 3 kDa membrane 
ultrafiltration permeate of a Pepsin+Pancreatin rapeseed protein digest (He et 
al., 2013c). The IC50 value was rather weak (520 µg protein/mL) when 
compared to the other identified ACE inhibitory rapeseed peptides, but Gly-
His-Ser was also shown to possess renin inhibitory activity with an IC50 value 
of 320 µg protein/mL. 
Recently, rapeseed hydrolysates, fractions and peptides have been reported 
to have antihypertensive effects on spontaneously hypertensive rats (SHR). The 
hypotensive effects of rapeseed hydrolysates and peptides are presented in 
Table 5 on page 27. Subtilisin digest of rapeseed protein has shown a dose-
dependent antihypertensive effect after oral administration to SHR with a 
significant decrease in blood pressure even at a single dose of 0.15 g/kg body 
weight (bw). Rapeseed protein-derived Alcalase and Pepsin hydrolysates have 
also shown appreciable antihypertensive effects, with Alcalase hydrolysate 
producing the greatest (−34 mm Hg) and fastest (4 h) decrease in systolic blood 
pressure (SBP). Permeate of rapeseed protein Pepsin+Pancreatin digest (<3 000 
Da) has induced a corresponding hypotensive effect (−21 mmHg) after oral 
dosage on SHRs. In comparison, the nonhydrolyzed canola protein isolate had 
a significant and more prolonged (24 h) SBP-reducing effect, which is 
attributable to the extensive protein hydrolysis in the gastrointestinal tract 
(Alashi et al., 2014). In contrast, trypsin hydrolysate has been reported to be 
ineffective at reducing hypertension in SHR after oral administration (Marczak 
et al., 2003). The current literature also includes information on 
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antihypertensive effects for rapeseed protein-derived pure peptides. Marczak 
and colleagues (2003) measured the antihypertensive activities of Val-Trp, Val-
Trp-Ile-Ser, Ile-Tyr and Arg-Ile-Tyr following oral administration to SHR. All 
peptides displayed a dose-dependent antihypertensive effect. Hypotensive 
activity of the peptides was compared between young (19 - 20 weeks) and old 
(28 - 30 weeks) SHRs. Usually the hypotensive effect of ACE inhibitors in old 
SHR is lower than in young SHR, but Arg-Ile-Tyr (rapakinin) showed a similar 
effect both in old and young rats. Thus, it was suggested that another 
mechanism besides ACE inhibition may be involved in the hypotensive effect 
of rapakinin. Subsequently, the hypotensive effect of rapakinin was found to be 
mediated mainly by the prostaglandin-cholecystokinin-dependent 
vasorelaxation (Yamada et al., 2010). Recently, the antihypertensive effects of 
the peptides Leu-Tyr, Thr-Phe and Arg-Ala-Leu-Pro from Alcalase digest of 
rapeseed protein were tested on SHR (He et al., 2013b). Single oral 
administration to SHR showed Leu-Tyr and Arg-Ala-Leu-Pro to be the more 
effective hypotensive agents with a maximum blood pressure reduction of -26 
and -16 mmHg, respectively, when compared to Thr-Phe (-12 mmHg). It was 
suggested that the higher number of hydrophobic amino acid residues of Leu-
Tyr and Arg-Ala-Leu-Pro contributed to their higher in vitro and in vivo 
activities when compared to Thr-Phe (He et al., 2013b). Oral administration of 
Gly-His-Ser to SHR showed a maximum blood pressure reduction of −17 
mmHg after 6 h. The in vitro ACE inhibitory effects of Gly-His-Ser were 
significantly weaker in comparison to the previously mentioned peptides and 
the hypotensive effects of Gly-His-Ser was suggested to be controlled mainly 
through renin inhibition (He et al., 2013b). The administration doses of single, 
pure rapeseed peptides reviewed above varied between 7.5 and 30 mg/kg bw, 
and the crude hydrolysates and fractions were administered in higher doses 
varying between 100 and 500 mg/kg bw. 
2.2.2.1.2 Antioxidant properties 
Rapeseed meal has been used as a source material for the production of 
peptides with antioxidant activities in several studies. Antioxidant effects of 
rapeseed hydrolysates and peptides have been observed with various different 
in vitro methods, either related to scavenging free radicals or inhibition of lipid 
peroxidation and formation of malondialdehyde (MDA). Most of the studies 
concern the utilization of commercial proteases for the production of 
antioxidant peptides, in particular, Alcalase has produced highly effective 
antioxidant capacity from rapeseed protein. Xue et al. (2009a) investigated the 
digestion of insoluble rapeseed meal protein with Alcalase and Flavorzyme to 
produce peptides with antioxidant properties and observed dose-dependent 
reducing antioxidant activities and hydroxyl radical scavenging abilities. The 
hydrolysate also inhibited malonyldialdehyde (MDA) generation by 50% in 
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blood serum at 150 mg/ml. The hydrolysate was separated into three fractions 
by size-exclusion chromatography and the fractions were found to inhibit the 
autohemolysis of rat red blood cells and MDA formation in a rat liver tissue 
homogenate (Xue et al., 2009b). Radical scavenging activity against DPPH 
radical and inhibition capacity against lipid peroxidation in a liposome system 
have also been demonstrated for rapeseed protein-derived Alcalase hydrolysate 
with comparable effects to those of ascorbic acid at 5 mg/mL (Zhang et al., 
2008; Zhang et al., 2009). In addition, two other studies have reported high 
antioxidant activities of rapeseed protein hydrolysates against free radicals, and 
in particular Alcalase hydrolysate showed high potential with the oxygen 
radical absorbance capacity (ORAC) method (He et al., 2013a; He et al., 
2013b). Antioxidant capacity against lipid peroxidation in a liposome system 
for rapeseed protein-derived hydrolysates has also been demonstrated by 
Mäkinen et al. (2012), and the highest antioxidant activity was obtained with 
Alcalase consistently with the other published data.  
Results have demonstrated a notable inverse relationship between radical 
scavenging activity (ORAC) and peptide molecular weight; the ORAC values 
were highest for the <1 kDa peptides but decreased as peptide size increased to 
5 - 10 kDa indicating that large-size peptides may not interact efficiently with 
the free radical (He et al., 2013a). On the other hand, Pihlanto and co-workers 
(2012) investigated the inhibition of lipid peroxidation of fermented rapeseed 
meal and different molecular weight fractions using a liposome model. 
Fermentation with L. helveticus and B. subtilis strains produced the capacity to 
inhibit lipid oxidation and fractionation with size exclusion chromatography 
separated the inhibition activity against lipid peroxidation in the 1 200 – 1 300 
Da fraction. This indicates that the peptides with lipid peroxide inhibitory 
properties are relatively higher in molecular mass than peptides with efficient 
radical scavenging properties. The difference could be due to the ability of 
larger peptides to bind into the liposome micelle structure.  
Relatively few rapeseed protein-derived antioxidant peptide sequences have 
been identified. Zhang and co-workers (2009) identified the peptide Pro-Ala-
Gly-Pro-Phe with high radical scavenging activity from the rapeseed protein 
Alcalase hydrolysate. This peptide corresponds to amino acid residues 38 - 42 
of napin. Antioxidative peptides with larger molecular sizes have been 
identified, for example from whey with 1 200 Da (Hernandez-Ledesma et al., 
2005), giant squid muscle with 747 and 1 307 Da (Rajapakase et al., 2005), and 
chicken essence with 1 400 Da (Wu et al., 2005).  
Altogether, due to the various different methods used for antioxidant 
determination, comparison of the reported results is not straightforward, but on 
the other hand, results show that rapeseed is a diverse source of different types 
of antioxidant peptides as the hydrolysates and fractions have shown the 
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capacity to prevent degenerative oxidative damage through different 
mechanisms. Also, the published data demonstrate that rapeseed hydrolysates 
have potentially high antioxidant potency as compared to other hydrolysates 
found in literature. For example, soy protein hydrolysates with Alcalase yielded 
ORAC values between 23 and 83.8 µM TE/g protein (Zhang et al., 2010) while 
amaranth protein hydrolysate produced by PP had a value of about 75 µM TE/g 
protein (Orsini Delgado et al., 2011), which are substantially lower than the 
values obtained with rapeseed hydrolysates. However, the nonprotein 
compounds, such as phenols and pigments need to be noted when evaluating 
the rapeseed samples. Rapeseed meal is known to be rich in phenolic 
compounds, most importantly sinapic acid derivatives (Vuorela et al., 2004). In 
the published data Alcalase has been consistently shown to be an excellent 
protease for releasing antioxidant peptides from rapeseed proteins; however, 
another report indicated that Flavourzyme should be selected to produce 
antioxidant peptides from rapeseed-like proteins (Cumby et al., 2008). 
2.2.2.1.3 Other bioactivities 
In addition to antioxidant and antihypertensive properties, some other 
potential health-enhancing properties have also been reported for rapeseed 
protein-derived peptides (Table 5). Rapakinin (Arg-Ile-Tyr) derived from 
rapeseed napin, has been reported to possess food intake-suppressing properties, 
in addition to the hypotensive properties. Rapakinin dose-dependently 
decreased food intake and gastric emptying after oral administration at a dose 
of 150 mg/kg in mice (Marczak et al., 2006). Rapeseed protein has also been 
linked to preventing insulin resistance. Mariotti and others (2008) demonstrated 
that substituting rapeseed protein for milk protein prevented the early onset of 
insulin resistance, and the effects corresponded to those achieved by 
manipulating dietary fat and carbohydrates in a rat model. 
Hypercholesterolemia is considered to be a major cause of heart diseases and 
atherosclerosis (World Health Organization, 2011). Healthy diet, exercise and 
consumption of bile acid sequestrants, which are better known as 
hypolipidemic agents, are important in the prevention of hyperlipidemia 
(Anderson and Siesel, 1990). Bile acid-binding promotes the consumption of 
cholesterol in the liver, which therefore reduces the level of cholesterol in the 
blood (Anderson and Siesel, 1990). The in vitro hypocholesterolemic properties 
of rapeseed proteins have been measured by determining the bile acid-binding 
capacity. Yoshie-Stark et al. (2008) demonstrated the bile salt-binding effects 
for rapeseed protein isolates and their hydrolysates, which were obtained by 
Pepsin and Pepsin/Pancreatin digestion. The concentration of bile salts used in 
this study corresponded to the physiological concentrations of bile acids in the 
human body (1.5–7 mM). Nevertheless, the hydrolysis treatments did not affect 
the bile acid-binding capacities indicating that some polypeptides present 
Review of the Literature 
 
25
already in the rapeseed protein isolates are able to bind the ligands (Yoshie-
Stark et al., 2008). Bile acid-binding properties of some other plant proteins 
and hydrolysates have also been reported with corresponding observations that 
hydrolysis does not necessarily enhance the bile acid-binding capacity (Yoshie-
Stark and Waesche, 2004; Ma and Xiong, 2009). 
Thrombosis is an anomaly in blood coagulation and leads to severe 
symptoms, heart injury among them. The blood-clotting process is related to 
the interaction between thrombin and fibrinogen to form the fibrin clot. 
Antithrombotics can reduce platelet aggregation and enhance fibrinolysis and 
thus, reduce the risk of thrombosis (Scheraga, 2004; Erdmann et al., 2008). 
Bioactive peptides have been demonstrated to possess antithrombotic activity, 
for example milk κ-casein-derived peptides and egg white protein hydrolysate 
(reviewed by Silva and Malcata, 2005). Recently, antithrombotic activity has 
also been demonstrated for rapeseed peptides (Zhang et al., 2008). The 
rapeseed peptide fractions produced with Alcalase hydrolysis had significant 
inhibitory activities on the thrombin-catalyzed coagulation of fibrinogen. The 
maximum inhibitory effect was 90% at peptide concentrations between 30 and 
50 mg/mL. The observed values were superior to those reported for egg white 
hydrolysate at the same concentration, but weaker than the antithrombotic 
activity of heparin, which is commonly used as an antithrombotic drug (Zhang 
et al., 2008). 
 T
ab
le
 5
 O
th
er
 p
ot
en
tia
l h
ea
lth
 e
nh
an
ci
ng
 p
ro
pe
rti
es
 o
f r
ap
es
ee
d 
pr
ot
ei
n-
de
riv
ed
 h
yd
ro
ly
sa
te
s a
nd
 p
ep
tid
es
 
So
ur
ce
 
m
at
er
ia
l 
Tr
ea
tm
en
t 
Sa
m
pl
e 
O
ut
co
m
e 
Re
fe
re
nc
e 
R
ap
es
ee
d 
m
ea
l 
Su
bt
ili
si
n 
Pe
pt
id
e 
A
rg
-I
le
-T
yr
 (r
ap
ak
in
in
) 
Su
pp
re
ss
ed
 fo
od
 in
ta
ke
 a
nd
 in
cr
ea
se
d 
C
C
K
 re
le
as
e 
in
 S
H
R
, V
as
or
el
ax
in
g 
ac
tiv
ity
 in
 m
es
en
te
ric
 a
rte
ry
 is
ol
at
ed
 fr
om
 
SH
R
 
M
ar
cz
ak
 e
t a
l.,
 2
00
6 
R
ap
es
ee
d 
 
Pe
ps
in
, 
Pe
ps
in
+P
an
cr
ea
tin
 
Pr
ot
ei
n 
is
ol
at
es
 o
bt
ai
ne
d 
by
 u
ltr
af
ilt
ra
tio
n 
or
 is
o-
pr
ec
ip
ita
tio
n,
 p
ro
te
in
 h
yd
ro
ly
sa
te
s 
H
yp
oc
ho
le
st
er
ol
em
ic
 a
ct
iv
ity
 in
 v
itr
o:
 b
ile
 
ac
id
-b
in
di
ng
 c
ap
ac
ity
 
Y
os
hi
e-
St
ar
k 
et
 a
l.,
 
20
08
 
D
eh
ul
le
d 
ra
pe
se
ed
 
A
lc
al
as
e 
Pr
ot
ei
n 
fr
ac
tio
n 
ob
ta
in
ed
 a
fte
r a
qu
eo
us
 
en
zy
m
at
ic
 e
xt
ra
ct
io
n 
of
 ra
pe
se
ed
, p
ro
te
in
 
hy
dr
ol
ys
at
e,
 p
ep
tid
e 
fr
ac
tio
ns
 o
bt
ai
ne
d 
af
te
r s
te
pw
is
e 
de
so
rp
tio
n 
w
ith
 2
5 
an
d 
55
%
 e
th
an
ol
 fr
om
 a
 n
on
po
la
r s
ty
re
ne
-
ba
se
d 
m
ac
ro
po
ro
us
 a
ds
or
pt
io
n 
re
si
n 
In
hi
bi
to
ry
 a
ct
iv
ity
 o
n 
th
e 
th
ro
m
bi
n-
ca
ta
ly
ze
d 
co
ag
ul
at
io
n 
of
 fi
br
in
og
en
 in
 
vi
tr
o 
Zh
an
g 
et
 a
l.,
 2
00
8 
R
ap
es
ee
d 
m
ea
l 
A
lc
al
as
e+
Fl
av
ou
rz
ym
e
Pr
ot
ei
n 
hy
dr
ol
ys
at
e 
A
nt
itu
m
or
 a
nd
 a
nt
io
xi
da
nt
 e
ff
ec
t i
n 
vi
vo
 in
 
a 
m
ur
in
e 
m
od
el
: d
ec
re
as
ed
 tu
m
or
 w
ei
gh
t 
in
 tu
m
or
-b
ea
rin
g 
fe
m
al
e 
m
ic
e,
 e
nh
an
ce
d 
su
pe
ro
xi
de
 d
is
m
ut
as
e 
ac
tiv
ity
 a
nd
 re
du
ce
d 
se
ru
m
 le
ve
l o
f t
hi
ob
ar
bi
tu
ric
 a
ci
d 
re
ac
tiv
e 
su
bs
ta
nc
es
 
X
ue
 e
t a
l.,
 2
00
9b
 
 
Review of the Literature 26 
Review of the Literature 
 
27
Rapeseed protein hydrolysate has also been shown to have antitumor effects 
in vivo on a tumor-bearing Kunming mice model (Xue et al., 2009b). Rapeseed 
protein hydrolysate significantly decreased the tumor weight by 44% and 53% 
with the gastric perfusion at 100 and 150 mg/kg/d, respectively, without 
causing mortality or growth retardation. Furthermore, rapeseed protein 
hydrolysate was found to enhance the superoxide dismutase activity and reduce 
the serum level of thiobarbituric acid reactive substances. The results suggested 
that an oral rapeseed protein hydrolysate administration may have an antitumor 
protective effect and may improve the immune function by reducing free 
radical formation and oxidative stress (Xue et al., 2009b).  
On the other hand, there is an increasing need for nonanimal-derived 
ingredients for culture medias used in the production processes of recombinant 
therapeutics due to the risk of contamination by animal-derived products. In 
this respect, the effects of rapeseed meal protein hydrolysates on cell growth 
and metabolism have been studied in animal cell line models. Chabanon et al. 
(2008) observed cell growth-increasing properties with rapeseed protein-
derived hydrolysates produced with various commercial proteases (Chabanon 
et al., 2008). Moreover, a peptide fraction was purified from the Alcalase-
hydrolyzed rapeseed protein with ultra- and nanofiltration, and the fraction 
stimulated significantly the growth rates of several animal cells and was 
observed to possess anti-apoptotic activity (Farges et al., 2008). The high 
nutritional value of rapeseed protein hydrolysates explains partly the positive 
effects on cell growth; however, the role of peptides in the anti-apoptotic 
activity has also been suggested (Chabanon et al., 2008; Farges et al., 2008). 
2.3 Targets for bioactive peptides used in this study 
As mentioned previously in the introduction, bioactive peptides may affect 
various molecular disease targets related to human health. The background for 
selecting ACE inhibitory activity and antioxidant activity amongst the 
multitude of activities as target properties is given in this section, as well as an 
overview of peptides’ structural characteristics related to these activities based 
on current literature. Also the methods used for assessing these bioactivities are 
briefly reviewed. 
2.3.1 Hypertension 
Hypertension constitutes a high risk factor for the development of 
cardiovascular diseases, stroke and end-stage renal disease (Daien et al., 2012). 
Figure 2 illustrates the key roles of renin and ACE in the physiological control 
of blood pressure through the RAS and the kinin-nitric oxide system. In 
pathological conditions there is an excessive level of angiotensin II, which 
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causes severe blood vessel contractions and limited relaxation to produce high 
blood pressure (Ibrahim, 2006). ACE has a dual effect preventing vasodilation 
by inactivating bradykinin, and activating vasoconstriction by converting 
angiotensin I into angiotensin II (Figure 2).  
 
 
Figure 2 The blood pressure-regulating renin-angiotensin system (RAS) 
pathway and the potential molecular targets (renin and ACE) for bioactive 
peptides. 
ACE inhibitors are widely used as antihypertensive agents and several drugs 
(captopril, enalapril, lisinopril etc.) are available as effective ACE inhibitors. 
Although there are various mechanisms involved in the regulation of blood 
pressure, inhibition of ACE still remains one of the crucial strategies in the 
treatment of hypertension (Aleixandre and Miguel, 2012). However, the 
synthetic ACE inhibitory drugs are not without side effects, such as a dry 
cough and angiodema. Nutraceuticals, bioactive peptides among them, provide 
the potential to avoid undesirable side effects and can decrease the growing 
costs of drug therapy (Shahidi and Zhong, 2008; Guang et al., 2012). Therefore, 
finding new sources of ACE inhibitors, especially in foodstuff, is of great 
interest. 
ACE inhibitory peptides are generally short sequences as the active site of 
ACE cannot accommodate large peptide molecules. Current literature on 
molecular mechanism of ACE inhibition by peptides indicate that C-terminal 
tri-peptide residues play a predominant role in binding to the active site of ACE, 
and hydrophobic (aromatic or branched side chains) amino acid residues of 
peptides correlate with enhanced inhibitory potential. In addition, it has been 
shown that single amino acid substitution, even with isomers, can greatly 
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influence the nature of interactions between peptides and ACE (Sato et al., 
2002). Recently, the mechanism of ACE inhibition by peptides was reviewed 
(Phelan and Kerins, 2011). The most effective ACE inhibitory peptides 
identified contain Tyr, Phe, Trp and/or Pro at the C-terminal. In addition, 
structure-activity data suggests that the positive charge of Lys and Arg as the 
C-terminal residue may contribute to the inhibitory potency (Ondetti et al., 
1977; Cheung et al., 1980; Ariyoshi, 1993). Quantitative structure-activity 
relationship (QSAR) modelling studies support the previous findings that C-
terminal bulky hydrophobic amino acids (for example Trp, Phe, Pro and Tyr) 
and N-terminal aliphatic amino acids (such as Leu, Ile and Val) are necessary 
features for ACE inhibition in the case of di- and tri-peptides (Wu et al., 2006a). 
On the other hand, QSAR studies indicate that in the case of 4-10 amino acids 
containing peptides the important determinant for ACE inhibition is that the 
last four C-terminal amino acids are predominantly hydrophobic (Wu et al., 
2006b). 
2.3.2 Oxidation 
Oxidative stress is both a cause and a consequence of hypertension; it 
induces cardiovascular and renal damage with associated increase in blood 
pressure. It has been shown, for example, that Angiotensin II-dependent 
hypertension is particularly sensitive to reactive oxygen species (ROS) (Uzuner 
et al., 2010). Therefore, therapies based on scavenging of ROS could have 
potential effects in the management of CVD, and food supplements containing 
antioxidants could be used to reduce the physiological oxidative damage. On 
the other hand, lipid oxidation is one of the most important oxidation processes 
in foods and it generates toxic compounds and undesirable odors and flavors 
(Laguerre et al., 2007). The potential health hazards of the synthetic 
antioxidants have caused widespread public concern, and thus there is a 
growing interest in natural antioxidants.  
The current literature offers abundant information on various food protein 
hydrolysates and peptides with antioxidant properties, e.g. from milk (Pihlanto, 
2006), egg (Davalos et al., 2004), barley hordein (Chiue et al., 1997), soybean 
(Pyo and Lee, 2007), canola (Cumby et al., 2008; He et al., 2013a) and potato 
(Wang and Xiong, 2005; Pihlanto et al., 2008). The oxidative reaction systems 
used for assessing antioxidant activities of the protein hydrolysates and 
peptides include scavenging of ROS or other free radicals and inhibition of 
ROS-induced oxidation of biological macromolecules such as lipids, proteins 
and DNA. An interesting phenomenon is that many of the antioxidative 
hydrolysates and peptides possess multifunctional properties, such as ACE 
inhibitory properties together with antioxidant capacity.   
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The antioxidative properties of the peptides are dependent on their structural 
and physicochemical characteristics, such as molecular size, hydrophobicity 
and amino acid composition (Pihlanto, 2006). The mechanisms of antioxidant 
activity of peptides are not fully understood, although different mechanisms 
have been demonstrated. The radical quenching activities have been suggested 
to be due to the ability of peptides to participate in single electron transfer 
reaction (Huang et al., 2005), and the other known mechanisms of antioxidant 
activity of peptides include metal-chelating activity and ferric-reducing power. 
Amino acids with electron-dense aromatic rings, Phe, Tyr and Trp can donate 
protons to electron deficient radicals. This property improves the radical 
scavenging properties of the amino acid residues (Chen et al., 1998; Pihlanto, 
2006). Hydrophobic amino acids are important for enhancement of antioxidant 
properties of peptides since they can increase the accessibility of the 
antioxidant peptides to hydrophobic cellular targets such as the polyunsaturated 
chain of fatty acids in biological membranes (Chen et al., 1998). Moreover, His 
residue of peptides can chelate metal ions, quench active oxygen and scavenge 
lipid peroxyl radical; these abilities were attributed to the imidazole group of 
His (Chan and Decker, 1994; Rajapakse et al., 2005). On the other hand, the 
sulfhydryl group of Cys has an important antioxidant activity due to its direct 
interaction with radicals (Qian et al., 2008). Cys residues of peptides can also 
serve as precursors for the synthesis of glutathione, a universal cellular 
antioxidant tripeptide, and thus Cys can contribute to the regeneration of the 
physiological antioxidant defense system (Meisel, 2005). In any case, in 
addition to the particular effects of the mentioned amino acids, the correct 
position of amino acids in the peptide sequence plays an important role in the 
antioxidant properties of peptides. It has also been reported that antioxidative 
peptides keep cells safe from damage by ROS through the induction of genes 
(Erdmann et al., 2008). Recently, casein hydrolysate has been shown to posess 
antioxidant activities in human Jurkat T cells (Lahart et al., 2011). Although 
the antioxidant activities of peptides have been studied in vitro quite 
extensively and the results are promising, it would be necessary to target the 
focus more on the in vivo effects of these peptides to evaluate the mechanisms 
of action more precisely and to enable application of these peptides in 
formulating health-promoting food products.  
2.3.3 Methods for assaying hypotensive and antioxidant properties 
in vitro and in vivo of food protein-derived bioactive peptides 
ACE inhibitory activity in vitro is generally evaluated by measuring the 
effect of potential inhibitors on the conversion of an appropriate substrate by 
ACE. There are several methods, and those based on spectrophotometric 
(Cushman and Cheung, 1971; Vermeirssen et al., 2002; Li et al., 2005) and 
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high-performance liquid chromatography (HPLC) assays are the most 
commonly utilized (Doig and Smiley, 1993; Hyun and Shin, 2000; Shalaby et 
al., 2006). The most commonly utilized substrate for ACE is Hippuryl-His-Leu 
(HHL), and the methods measure the catalytic activity of ACE to produce 
hippuric acid from the substrate (Cushman and Cheung , 1971; Doig and 
Smiley, 1993; Li et al., 2005; Shalaby et al., 2006). In the widely used 
spectrophotometric method of Cushman and Cheung (1971) the hippuric acid 
released is measured after its extraction with ethyl acetate. The hippuric acid 
can also be measured by HPLC assays avoiding the extraction step 
(Vermeirssen et al., 2002). However, 2-furanacryloyl-phenylalanylglycyl-
glycine (FAPGG) can also be used as substrate for ACE (Holmquist et al., 
1979). This method has also been applied in microtiter plates (Vermeirssen et 
al., 2002). Moreover, substrates such as o-aminobenzoylglycyl-p-
nitrophenylalanylproline are designed for fluorometric assays (Carmel and 
Yaron, 1978; Sentandreu and Toldrá, 2006).  
On the other hand, another strategy for the selection of potential food-
derived antihypertensive peptides is to search for in vitro renin inhibitory 
activity. Renin inhibition could provide a more complete blockade of the RAS, 
since renin catalyzes the rate-determining step in RAS (Fitzgerald et al., 2011). 
Recent studies have reported renin inhibition capacity, for example from 
rapeseed protein-derived hydrolysates and peptides (He et al., 2013a; He et al., 
2013b; Alashi et al., 2014). The in vitro renin inhibitory capacities have been 
measured with a fluorometric method using a human recombinant renin 
inhibitor screening assay kit (Cayman Chemical, Ann Arbor, MI, USA). 
Interestingly, several peptides have shown dual inhibition capacity both for 
ACE and renin (He et al., 2013b).     
In vitro cultured cell model systems are used for screening of compounds for 
their bioavailability, metabolism and bioactivity to obtain valuable information 
before expensive and time-consuming in vivo studies. Endothelial cell models 
are commonly utilized, particularly in angiogenesis research. Endothelial 
dysfunction initiates atherosclerosis and the dysfunction is characterized by 
alteration in nitric oxide and endothelin-1 homeostasis (Verma et al., 2003). 
There are several assays available to analyze the effects of bioactive 
compounds, such as bioactive peptides, on the endothelial function in vitro. For 
example, expression and activation of endothelial nitric oxide synthase – the 
enzyme responsible for the release of the vasodilator compound nitric oxide – 
can be analyzed in endothelial cells in vitro to elucidate the effects of the 
compounds of interest on the potential release of nitric oxide in the vascular 
endothelium. 
Methods for assaying antioxidant capacity in vitro are various. Oxidative 
processes occurring in food or biological systems are complex, and thus the 
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antioxidative mechanisms by which bioactive compounds may act are various. 
Therefore, finding one method for characterizing the overall antioxidative 
potential of food is not relevant. Nevertheless, the current literature describes 
methods such as the Trolox equivalent antioxidant capacity (TEAC) assay, total 
radical-trapping antioxidant parameter (TRAP) assay, and oxygen radical 
absorbance capacity (ORAC) assay for measuring the antioxidative capacity of 
food and biological samples (Cao and Prior, 1998; Re et al., 1999). Commonly 
used assays include measuring the inhibition of lipid peroxidation in a linoleic 
acid model system and in the liposome model, and the capacity to scavenge the 
ABTS and DPPH radicals. In particular, the antioxidant mechanisms in human 
health promotion go beyond the antioxidant activity of scavenging or 
quenching free radicals, and thus the use of cell culture models for antioxidant 
research is particularly important (Liu and Finley, 2004). Intracellular oxidative 
stress, for example in endothelial cells, can be induced with a peroxy generator 
(Elisia and Kitts, 2008), and subsequently the extent of intracellular radical 
formation can be measured in the presence and absence of antioxidative 
compounds (Wolfe and Liu, 2007). 
The antihypertensive effects in vivo can be assessed in SHR, which 
constitute an accepted animal model for studying human essential hypertension 
(Erdmann et al., 2008). This animal model has been widely used to study the 
hypotensive effects of ACE inhibitory milk protein-derived peptides in both a 
short-term and long-term manner (Fitzgerald et al., 2004; Erdmann et al., 2008), 
and the current literature also includes studies concerning the in vivo 
antihypertensive effects of plant protein-derived peptides in SHR, e.g. pea 
(Vermeirssen et al., 2005), canola (Alashi et al., 2014) and flaxseed (Udenigwe 
et al., 2012). The published data concerning the in vivo measurement of the 
antioxidant effects of food protein-derived bioactive peptides is quite limited; 
however, biomarkers of lipid and protein peroxides as well as DNA damage 
can be assessed to monitor changes in oxidative stress in vivo.  
2.4 Production of food protein-derived bioactive peptides 
Bioactive peptides can be released by fermentation, food processing and 
enzyme-catalyzed proteolysis in vitro or in the digestive tract after human 
consumption (Hartmann and Meisel, 2007). Numerous animal and plant protein 
sources have been exploited as sources of bioactive peptides. Most widely 
studied protein sources are of animal origin, such as milk proteins and egg, but 
marine and plant protein sources have attracted increasing attention in recent 
years. For example chum salmon collagen (Yang et al., 2009), Pacific oysters 
(Wang et al., 2010) and shrimp cell by-product (Kannan et al., 2011) have been 
utilized as sources of bioactive peptides with immunostimulating and antitumor 
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properties. Various plant protein sources have been utilized for bioactive 
peptide production, of which soy, pulses (lentils, peas, beans, chickpeas), 
cereals, canola and flaxseed are the typical sources. Based on the current 
literature, there are two major criteria for the selection of source materials – 
firstly a pursuit of value-added use of abundant underutilized protein-rich food 
industry by-products, and secondly utilization of proteins containing specific 
peptide sequences of particular bioactivity interest. In particular, the 
combination of these two criteria could lead to the selection of excellent protein 
sources of bioactive peptides. However, this strategy for selection is restricted 
due to the fact that the detailed knowledge of structure-function properties of 
active sequences has been rather limited and hampered thus far. 
The specific bioactivity of food protein-derived peptides against different 
molecular disease targets depends primarily on structural and physicochemical 
properties such as the molecular size, hydrophobicity and side chain bulkiness 
of the amino acid residues (Pripp et al., 2005). During the enzymatic 
production of bioactive peptides several factors affect the resulting peptide 
composition, and their structural and physicochemical characteristics. These 
factors include the specificity of the enzyme used for hydrolysis, hydrolysis 
time, enzyme to substrate ratio, and pretreatment of the protein prior to 
hydrolysis. For example, thermal treatment of proteins can enhance enzymatic 
hydrolysis (Inouye et al., 2009). 
According to the current literature, enzymatic hydrolysis with single or 
multiple specific or nonspecific proteases has been the main process for 
producing ACE inhibitory and antioxidative peptides from food proteins 
(Pedroche et al., 2002; Wu and Ding, 2002; Yust et al., 2003; Megías et al., 
2006; Barbana and Boye, 2010; Udenigwe and Aluko, 2010; Udenigwe et al., 
2012). Industrial food-grade proteinases such as Alcalase, Flavorzyme, and 
Protamex derived from microorganisms, as well as enzymes from plant (e.g. 
Papain) and animal sources (e.g. Pepsin and trypsin), have been widely used in 
producing ACE inhibitory and antioxidative peptides. In the case of several 
plant proteins, the serine-type endoprotease, Alcalase has produced the highest 
ACE inhibitory activities in vitro. A simulated gastrointestinal digestion 
process could be a cost-effective method for producing ACE inhibitory 
peptides since extensive processing of the peptide product would not be needed 
(Vermeirssen et al., 2004a). Several studies have demonstrated the release of 
potent ACE inhibitory peptides from plant proteins during digestion with either 
Pepsin alone or in combination with trypsin, chymotrypsin and/or Pancreatin. 
For example, digestion of red lentils and pea proteins with trypsin, Pepsin and 
chymotrypsin (Vermeirssen et al., 2004b; Boye et al., 2010; Barbana and Boye, 
2011) has resulted in high ACE inhibitory potencies.   
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On the other hand, a number of studies have shown that antihypertensive 
peptides are liberated during fermentation. In particular, fermented milk 
products fermented with lactic acid bacteria strains have been found to possess 
antihypertensive and antioxidative capacity (Virtanen et al., 2007; Pihlanto et 
al., 2010). Furthermore, several antioxidative and ACE inhibitory peptide 
sequences have also been identified from fermented milk (Hernández-Ledesma 
et al., 2005). Fermentation has also been shown to release ACE inhibitory and 
antioxidant peptides from plant proteins, such as soybean. For example, the 
traditional fermented soybean products natto, tempeh and douche contain 
antioxidative and ACE inhibitory peptides released by fungal proteases. 
However, enzymatic hydrolysis has been shown to produce higher potent 
bioactivities than fermentation especially from plant proteins. 
2.4.1 Processing methods 
A challenge frequently faced in food protein-derived peptide research is how 
to process the protein hydrolysates further in order to obtain high-yield peptide 
products with enhanced bioactivity. After protein hydrolysis, the resulting 
bioactive peptides can be concentrated based on physicochemical and structural 
characteristics of the peptides of interest, to enhance the bioactivity. The 
peptide properties that are often focused on include size, net charge and 
hydrophobicity, depending on the targeted bioactivities. The crude protein 
hydrolysate can be further processed by being passed through ultrafiltration 
membranes and size-exclusion chromatography in order to obtain a more 
uniform product with the desired range of molecular mass, especially to 
concentrate low molecular-weight peptides that are more resistant to further in 
vivo proteolytic digestion and more potential ACE inhibitors. In addition, 
reverse-phase chromatography on a hydrophobic column matrix can be used to 
fractionate peptides according to hydrophobicity, and ion exchange 
chromatography with selective columns can be utilized to produce peptide 
fractions of a particular net charge (Pownall et al., 2010; Pownall et al., 2011). 
These approaches are very advantageous especially when the peptide properties 
that inhibit the molecular disease targets are known – for example antioxidant 
activities of peptide fractions have been demonstrated to correlate negatively 
with cationic property (Pownall et al., 2011). A novel membrane technology 
known as electrodialysis-ultrafiltration is useful for separating cationic, anionic 
and neutral peptides with defined molecular size on a large scale (Firdaous et 
al., 2009). Recently, this method has been utilized to concentrate and separate 
low molecular-weight bioactive peptides with a net positive or negative charge 
(Doyen et al., 2011a; Doyen et al., 2011b). Absorbent materials, such as 
activated carbon, are applicable for enriching particular amino acids in food 
protein hydrolysates (Udenigwe and Aluko, 2010). This processing method can 
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result in sufficient yield if the amino acid residues of the target are prevalent in 
the peptides of interest. In addition, there are extensive bioassay-guided 
purification methods for the isolation of pure peptides for further analysis, 
especially for structure-function investigations. However, low peptide yield is 
still a limiting factor of the feasibility of using food protein-derived bioactive 
peptides. Therefore, it would be relevant to develop large-scale applicable 
food-grade processing methods for the production of a high yield of highly 
active peptide fractions. Understanding the unique structural characteristics of 
peptides with targeted bioactivity and exploitation of these characteristics in the 
concentration of the particular peptides is a crucial requirement for this 
approach. 
2.5  Delivery and bioavailability of bioactive peptides 
The in vivo effects of any suggested health-promoting agent in foods are 
dependent on their bioavailability. After consumption, they need to appear in 
the blood to a significant extent to reach the target sites, except for the target 
sites in the gastrointestinal tract. The bioavailability is determined by several 
variables, such as gastric digestion, metabolism by the intestinal microflora, 
absorption and interactions with the intestinal mucus and epithelium, plasma 
kinetics, the nature of circulating metabolites, cellular uptake and metabolism. 
A complex enzyme battery is involved in the hydrolysis of proteins and 
peptides in the human gastrointestinal tract. The enzymes are located in various 
sites and they generally network in a synergistic manner with other peptidases 
(Zhang et al., 2011). The gastric digestion in the stomach starts with the action 
of Pepsin and is followed by the intraluminal digestion in the small intestine 
where the polypeptides are further cleaved by pancreatic proteases, such as 
trypsin, chymotrypsin, elastase and carboxypeptidase. The battery of brush 
border peptidases digests the polypeptides further at the intestinal brush border 
membrane, which is particularly rich in aminopeptidase activity. Furthermore, 
the microorganisms of the colon produce large numbers of peptidase enzymes 
which also participate in protein digestion. The small intestine is the principal 
site of absorption. After absorption to blood circulation peptides are exposed to 
serum peptidases which can further hydrolyze the peptide bonds (Zhang et al., 
2011). However, peptides that act in the gastrointestinal tract, for example 
cholesterol-binding and anorectic peptides, do not have to be absorbed to exert 
their biological properties (Wang et al., 2005). 
As human studies are time-consuming, costly and restricted by ethical 
concerns, the development of in vitro models for investigating the effects of 
digestion on the bioactive peptides has attracted much attention. A plethora of 
models have been implemented to simulate gastrointestinal digestion; most 
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typically models simulate digestion in the oral cavity, the stomach and the 
small intestine. There is substantial variability among the conditions, such as 
the time of digestion, agitation, enzymes and concentrations of the salts and 
bile acids used. Moreover, there is great differentiation in the inclusion of 
various digestion stages and whether the chosen conditions are static with fixed 
concentrations of enzymes and bile acids etc., or dynamic with varying 
concentrations of these constituents. For instance, human digestive liquids have 
been utilized to model digestion in vitro (Eriksen et al., 2010; Mäkinen et al., 
2012), and meanwhile several reports have concerned the implementation of 
porcine enzyme mixtures (for example, Vermeirssen et al., 2003; Lo and Li-
Chan, 2005; Marambe et al., 2011). The diversity of model conditions has 
hampered the ability to compare results across the different studies. Thus, a 
consensus concerning the basic parameters would be relevant in order to 
harmonize the various in vitro digestion models. Recently, in vitro models for 
studying the digestion of secondary plant metabolites (such as polyphenols) 
were reviewed by Alminger et al. (2014). A set of parameters for static in vitro 
models was suggested based on relevant in vivo data. Thus far, such a 
harmonization of parameters based on in vivo data has not been reported for 
modeling the bioavailability of peptides.  
In general, small peptides – di-peptides and tri-peptides – have shown in 
vivo bioactivity and resistance to peptidolysis, and can be absorbed intact 
across the intestine in adequate amounts to reach peripheral target sites 
(Gardner, 1998; Foltz et al., 2009; Darewicz et al., 2011). Smaller peptides are 
transported across the enterocytes through intestinal-expressed peptide 
transporters whereas oligopeptides may be absorbed by passive transport 
through hydrophobic regions of membrane epithelia or tight junctions 
(Darewicz et al., 2011).  
The need for technological tools for the improvement of bioavailability is 
reinforced, and the focus is on the improvement of limited stability and 
absorption peptides. Bioactive peptides can be administered in different vehicle 
matrices, such as beverages and bakery products (Hernández-Ledesma et al., 
2011). The current literature includes many strategies for enhancing the 
bioavailability of bioactive compounds (Nestor, 2009): for example, 
microencapsulation for controlled release of the active compounds, 
stabilization of the active molecules to improve the resistance against 
degradation, and the development of peptide analogues with enhanced stability 
(Matoba et al., 2001; Yamada et al., 2002; Gomez-Guillen et al., 2011). In 
addition, amendment of fiber to the meal has been observed to improve the 
bioavailability of the tri-peptides Val-Pro-Pro, Ile-Pro-Pro and Leu-Pro-Pro 
(Kies and Van Der Pijl, 2012) and carriers interacting with the peptide 
molecule have been reported to facilitate intestinal uptake (Shaji and Patole, 
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2008). However, no general strategy for improving the bioavailability of 
antihypertensive peptides has been found thus far, and each case needs to be 
studied separately depending on the characteristics of the peptides of interest. 
2.6 Hypotensive effects in vivo of plant protein-derived 
bioactive peptides 
The published data demonstrates antihypertensive effects of ACE inhibitory 
protein hydrolysates and peptides derived from various plant sources. Several 
studies have utilized the SHR model for studying the potential in vivo 
hypotensive properties after either oral or intravenous administration. The 
hypotensive effects in vivo reported for plant protein-derived peptides and 
hydrolysates are summarized in Table 5.  In addition to the investigations on 
SHR, published data includes observations of the antihypertensive effects of 
yam tuber (Dioscorea alata) protein in a clinical trial. Lin and co-workers 
(2006) purified and hydrolyzed yam tuber storage proteins, dioscorins, with 
Pepsin and demonstrated an antihypertensive effect firstly on SHR. At the same 
time, the unhydrolyzed dioscorin isolate also showed a significant 
antihypertensive effect in SHR (Table 5). Subsequently, the antihypertensive 
effect of the dioscorin isolate was evaluated in a clinical randomized, placebo-
controlled crossover study in human subjects (Liu et al., 2009). The dioscorin 
meal or placebo was administered as a daily drink, and a significant decrease in 
systolic and diastolic blood pressure was observed after the five weeks of 
dioscorin drink intervention (Table 5). The dioscorin isolates consisted mostly 
of protein, and thus the observed antihypertensive effects were related to 
peptide released from dioscorins during the gastrointestinal digestion. However, 
the nonprotein compounds may still have some minor effect on the results. 
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2.7  Theory synthesis and hypothesis of the study 
Cardiovascular diseases are a global health threat and improved nutrition is 
important to tackle the expected rise in global CVD incidence and societal 
burden. Hypertension constitutes a high risk factor for the development and 
causatives of CVD. Nutraceuticals, such as bioactive peptides, may help in the 
prevention of hypertension and CVD as a part of a healthy diet and lifestyle. 
ACE is an important agent causing hypertension and ACE inhibitors are widely 
used in the treatment of hypertension. At the same time, oxidative stress is 
related to numerous pathological conditions, and in particular, it induces 
cardiovascular and renal damage with associated with hypertension. Thus, ACE 
inhition and antioxidant effects are potential molecular targets for bioactive 
peptides to prevent hypertension and enhance cardiovascular health. Bioactive 
peptides can be produced from various protein sources and an important aspect 
in the selection of source materials is the utilization of abundant by-products 
from the food industry. Huge amounts of protein-rich by-products are formed 
in the potato starch industry and in the rapeseed oil industry, and due to the 
high-quality protein content, rapeseed meal and potato fractions are potential 
source materials for the production of bioactive peptides. Moreover, a vast 
amount of potato is discarded from the food industry and utilization of the 
discarded potatoes for the production of bioactive peptides could enhance the 
value of the entire production chain.  
The hypothesis of the present study was that bioactive peptides with 
antioxidant and ACE inhibitory properties could be produced from rapeseed 
and potato proteins by developing an effective enzymatic hydrolysis process, 
and putatively as well by fermentation with proteolytic microbial strains. It was 
hypothesized that the ACE inhibitory peptides could be concentrated by 
physicochemical characteristics to enhance the ACE inhibitory capacity and 
potential bioavailability based on known structural characteristics related to 
these properties; small molecular size and the presence of hydrophobic amino 
acid residues are known to correlate with enhanced ACE inhibitory activity and 
increased bioavailability. It was also hypothesized that preliminary testing of 
the potential bioavailability of the ACE inhibitory peptides with a proper in 
vitro digestion model would offer valuable information on the potential of the 
peptides to induce antihypertensive effects in vivo. Furthermore, according to 
the synthezised theory, it was conceivable that studies on animals would be 
needed to evaluate the in vivo antihypertensive effect. 
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3 AIMS OF THE STUDY 
The objective of this thesis was to evaluate the suitability and potential of 
the industrial potato fruit liquid and rapeseed meal for the production of 
bioactive peptides with ACE inhibitory and antioxidant properties. Furthermore, 
the aim was to evaluate the effects of the peptides on blood pressure in vivo in 
animals. 
 
Briefly, the main aims of the present study were: 
 To produce bioactive peptides with ACE inhibitory and antioxidant 
properties from by-products of rapeseed oil industry and potato starch 
industry by enzymatic hydrolysis and fermentation (I, II, III, IV) 
 To concentrate the peptides by physicochemical and structural 
characteristics in order to enhance the ACE inhibition properties and 
potential bioavailability (I, III) 
 To elucidate the bioavailability of the ACE inhibitory peptides by 
measuring the resistance of the peptides against peptidolysis in a 
digestion model in vitro using human digestive liquids (III) 
 To study the potential of the peptide concentrate to prevent the 
development of hypertension in vivo in a 2K1C rat model (V) 
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4 MATERIALS AND METHODS 
This section is a summary of the materials and methods used in the present 
study and detailed information is described in the original publications (I - V). 
4.1 Sample material for production of potato protein-
derived enzymatic hydrolysates with antioxidant and 
ACE inhibitory properties (I) 
Mature potato tubers (Solanum tuberosum) of cv. Lady Christl and Asterix, 
new-season harvested “immature” tubers of cv. Timo and sprouted tubers of cv. 
van Gogh cultivars were purchased from a local supplier. In addition, industrial 
potato by-product fractions were obtained from companies producing starch 
and processed potato products. The fractions were: the particulate fraction 
called potato pulp, and the liquid part obtained after filtration of the pulp 
obtained from potato starch production, and peel obtained from the 
manufacture of potato products. The proteins from potato tubers were extracted 
by the aqueous extraction method described by Ralet and Gueguen (2000). 
The proteolytic enzyme preparations used for the hydrolysis of potato 
proteins were Alcalase (2.4 U/mg, protease from Bacillus licheniformis), 
Esperase (8 U/mg, from Bacillus sp.) and Neutrase (0.8 U/mg, from Bacillus 
amyloliguefaciens) from Sigma Chemical (St. Louis, MO). 
4.2 Sample material for production of potato protein-
derived ACE inhibitory peptides by autolytic process (II) 
For the autolysis study the potato cultivar Asterix was grown in the seed 
potato farm of Pohjoisen Kantaperuna Oy (Yppäri, Finland: latitude 64.40° 
north and longitude 24.09° east) and samples were taken at different stages of 
potato tubers’ life cycle: (i) immature tubers 86 days post planting (dpp) (plants 
at flowering stage), (ii) tubers at early maturing stage at the time of haulm 
killing (112 dpp), (iii) mature tubers at harvest time (133 dpp), (iv) dormant 
tubers after 2.5 months and (v) 5 months in storage, (vi) tubers ready to sprout 
following 6.5 months in storage, and (vii) tubers stored for 6.5 months and 
sprouted for 14 days. At each sampling time, 5 kg of tubers was taken and a 
subsample of 1 kg including tubers of all sizes (diameter 30 - 70 mm) was used 
for analysis. 
Proteins were extracted separately from whole-tuber samples, vascular tissue 
enriched fraction, pith fraction and peels (Figure 3) by aqueous extraction 
(Ralet and Gueguen, 2000) and frozen at -70 °C until analysis and autolysis 
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treatment. Protein contents of the protein extracts were measured by the DC 
Protein Assay (Bio-Rad Laboratories, USA) and dry matter was measured by 
drying 500 µl of extract in the oven at 102 °C for 20 h. 
 
 
 
 
Figure 3 Peel, vascular bundle and pith fractions of the potato tuber used for 
analysis. 
In order to elucidate the capacity of potato protein isolates to hydrolyze 
endogenous proteins into peptides with ACE inhibitory activity, peptidase 
activities were measured using p-nitroanilide amino acid substrates as 
described by Peltoniemi (2004). Prior to the analysis, samples were filtered 
through a 5 kDa membrane (Millipore) to remove interfering compounds such 
as salts and sugars.  
4.2.1 Autolysis treatments 
Firstly, the autolysis was performed at different temperatures, in various pH 
conditions and with different durations to evaluate the optimal conditions for 
autolysis. After this, protein isolates from different parts of potato tubers were 
subjected to autolysis separately and ACE inhibitory activities were measured 
during the autolysis. Furthermore, the autolysis was performed with the 
addition of potato proteins as putative sources of ACE inhibitory peptides. The 
autolysis treatments are presented schematically in Figure 4. 
Pith  
Vascular bundle  
Peel 
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Figure 4 Implementation and different stages of the potato autolysis study. In 
the upper part, the solutions in the picture are protein extracts from peel (A), 
vascular bundle (B) and pith (C) fractions, and whole tubers (D). 
Two types of protein preparate were used for amendment. The added 
proteins were purified recombinant potato protein produced in Escherichia Coli 
Potato tubers at seven
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stages
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Protein extraction
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predicted to produce six bioactive VPP tripeptides per molecule, and secondly 
a crude protein concentrate of potato proteins (Figure 4). The protein 
concentrate was a retentate from ultrafiltration of potato protein extract with a 
10 000 Da MWCO membrane. 
4.3 Sample material for production of rapeseed protein-
derived bioactive peptides by means of enzymatic 
hydrolysis and fermentation (III, IV) 
The rapeseed (B. napus) was a by-product from the rapeseed industry: 
milled rapeseed after oil recovery from Raisio Group Ltd., Finland. Protein 
isolation from the rapeseed meal was carried out using a method described by 
Bérot et al. (2005). The proteolytic enzyme preparations used for the hydrolysis 
of rapeseed protein were Alcalase (2.4 U/mg, protease from Bacillus 
licheniformis), trypsin (8.750 U/mg, trypsin from bovine pancreas), Pepsin 
(2.174 U/mg, Pepsin from porcine stomach mucosa), Subtilisin (11 U/mg, 
protease Subtilisin Carlsberg) and Thermolysin (42 U/mg, Thermolysin from 
Bacillus thermoproteoliticus) from Sigma Chemical (St. Louis, MO). 
Fermentation was performed with four proteolytic microbial strains: 
Lactobacillus helveticus CNRZ32, Lactococcus lactis ssp. lactis 20481, 
Kluyveromyces marxianus ATCC 28244 and Bacillus subtilis ATCC 21394, for 
48 h at 30 °C. The ACE inhibitory and antioxidant activities were followed 
during the hydrolysis and fermentation treatments.  
4.4 Sample material for producing rapeseed protein-derived 
peptide fraction for in vivo measurement of 
antihypertensive effects on 2K1C animals (V) 
Rapeseed (B. napus) meal was obtained after industrial oil recovery from 
Raisio Group Ltd., Finland. Two different batches of milled rapeseed were 
used for the in vivo studies; the batches originated from two separate harvesting 
seasons. The protein extraction was performed separately from the two batches 
according to Bérot et al. (2005).  
Prior to the in vivo studies on animals, rapeseed protein extracts were 
hydrolyzed with Alcalase and the hydrolysate was subjected to a solid-phase 
extraction and membrane filtration in order to produce a concentrate of small 
hydrophobic rapeseed peptides. The solid-phase extraction was performed with 
Sep-Pak C18 cartridges and the retained compounds were eluted with a 
stepwise gradient (15% and 60%) of ACN and 0.1% TFA in water. The 
fraction which was eluted between 15 and 60% ACN, was further subjected to 
ultrafiltration with a 3 000 Da MWCO membrane. Permeates were pooled, 
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dried under vacuum and stored at -20 °C until analysis. The peptide 
concentrates were prepared separately for the in vivo animal test phase 1 and 
phase 2 and were designated as RPHF ph1 (used for animal study phase 1) and 
RPHF ph2 (respective peptide fraction for animal study phase 2).  
4.5 Measurement of selected bioactivities in vitro (I, II, III, 
IV, V) 
4.5.1 Determination of ACE inhibitory activity  
The method used for determining ACE inhibitory activity was that described 
by Hyun and Shin (2000). The IC50 value was defined as the concentration of 
peptide in mg protein/ml required to reduce the height of the hippuric acid peak 
(50% inhibition of ACE). ACE inhibition mechanisms of selected peptide 
fractions were estimated by means of enzyme kinetics and the Lineweaver–
Burk plot (III). Inhibition types and kinetic parameters were estimated by a 
nonlinear regression fit using GraphPad Prism version 5 (GraphPad Software, 
San Diego, CA, USA).  
4.5.2 Determination of inhibitory activity on lipid peroxidation (III, 
IV)  
The capacity of hydrolysed or fermented rapeseed samples to inhibit lipid 
peroxidation was tested with soybean phosphatidylcholine liposomes in an Fe-
ADP system. Liposomes were prepared according to the method of Ursini et al. 
(1982) and malondialdehyde equivalents (MDAeqv) were measured according 
to the methods of Tirmenstein et al. (1998) and Harper and Hadley (1990) with 
some modifications. Briefly, liposomes were mixed with sample and oxidative 
agent (Fe-ADP) in a phosphate buffer solution in various sample 
concentrations. The concentration of the thiobarbituric acid reactive substances 
(TBARS) formed during liposome oxidation was determined by a color 
reaction with thiobarbituric acid (TBA) and butylated hydroxytoluene (BHT) 
(532 nm). The concentration of TBARS was calculated using the 
malondialdehyde (MDA) standard curve prepared. A control sample was 
prepared using a corresponding procedure without sample amendment and 
vitamin E was used as a positive control for inhibition. The oxidation inhibition 
percentage was defined as follows: [(MDAcontrolΔ48h–
MDAsampleΔ48h)/MDAcontrolΔ48h]×100%. 
Materials and Methods 
 
48 
4.5.3 Scavenging activity of ABTS radical by spectrophotometry and 
total radical-trapping potential method (TRAP) (I)  
The scavenging activity of potato hydrolysates against the ABTS radical 
[2,20-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)] was determined by the 
decolorization assay of Re et al. (1999). The potato hydrolysates with the 
highest radical scavenging activities were measured by the TRAP method 
described by Lissi et al. (1995).  
4.6 Measuring the resistance of ACE inhibitory peptides to 
gastrointestinal digestion (III) 
To mimic digestion in the stomach and duodenum, an in vitro digestion 
assay was carried out as described by Almaas et al. (2006). The tested sample 
was rapeseed protein-derived Alcalase hydrolysate. The digestion was 
performed by shaking samples with human gastric juice at pH 2 and 
subsequently with human duodenal juice at pH 8, both steps for 30 min at 
37 °C. To analyze the degradation of rapeseed hydrolysate proteins during the 
digestion, the samples withdrawn during the digestion treatment were subjected 
to protein electrophoresis. ACE inhibitory activity was followed during the 
treatment. 
4.7 Characterization of the samples (II, III, IV) 
4.7.1 Size-exclusion chromatography (III, IV) 
The effects of hydrolysis and fermentation treatments on the molecular size 
distribution of rapeseed samples were determined using size-exclusion 
chromatography. Molar mass distribution was determined using a calibration 
curve obtained using b-lactoglobulin (18 400 Da), aprotinin (6 512 Da), 
bacitracin (1 410 Da), Hip–His–Leu (430 Da) and Leu–Gly (188 Da).  
4.7.2 Two-dimensional (2D) gel electrophoresis (II) 
The effect of autolysis treatment on the protein compositions of potato 
protein extracts was measured by 2D gel electrophoresis. Potato protein 
samples were first subjected to an isoelectric focusing after which the migrated 
proteins were separated according to molecular size with SDS-PAGE. A mass 
spectrometry-compatible silver-staining protocol was used to visualize the 
proteins. In the analysis of tuber pith fraction, the samples were purified by 
ultrafiltration with a 3 000 Da MWCO membrane before analysis to remove 
Materials and Methods 
 
49
interfering compounds such as salts and sugars; the retentate was subjected to 
the analysis.  
4.7.3 Analysis of proteins from 2D gels by mass spectrometry (MS) 
(II)  
Selected proteins from 2D gel spots were analyzed at the Turku Centre for 
Biotechnology (Turku, Finland) in order to identify the proteins degraded 
during the autolysis treatment as putative sources of ACE inhibitory peptides. 
Protein spots were picked with a scalpel, washed with NH4HCO3/ACN to 
remove impurities and subjected to an in-gel trypsin digestion after which 
peptides were desalted by a solid-phase extraction with a C18 membrane (3M). 
Desalted samples were analyzed with MALDI-TOF/TOF with Matrix Science 
Mascot Search program (Ohio Supercomputer Center, Columbus, OH). The 
Swiss-Prot protein knowledgebase 51.7 (http://www.expasy.org/sprot/) was 
used to search amino acid sequences of known proteins. 
4.8 Characterization and identification of ACE inhibitory 
peptides (I, IV, V) 
4.8.1 Concentration of peptides (I, III, IV)  
Solid-phase extraction with Sep-Pak C18 cartridges (Waters, Milford, USA) 
was utilized in order to diminish nonprotein compounds such as salts from the 
samples prior to the chromatographic purification of peptides. Moreover, solid-
phase extraction was utilized for prefractionation of the peptides according to 
the hydrophobic properties. The retained compounds were eluted with a 
stepwise gradient (10, 30 and 60 %) of ACN. Ultrafiltration was used for 
further concentration of the ACE inhibitory and antioxidant peptides. In the 
case of potato samples, ultrafiltration was performed with 3 000, 5 000 and 
10 000 Da MWCO membranes, whereas with rapeseed samples 3 000 Da 
MWCO was used. Retentates and permeates were subjected to analysis of 
protein content and bioactivities.  
4.8.2 Size-exclusion chromatography (IV)  
To elucidate whether the observed bioactivities of the fermented rapeseed 
samples were due to peptides produced during the fermentation, fractions were 
collected from the size-exclusion chromatography. Fractions were collected at 
2 min intervals using automated fraction collector, concentrated by freeze-
drying and analyzed for inhibitory capacities against ACE and lipid 
peroxidation. 
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4.8.3 Reversed-phase HPLC (I, V)  
In order to analyze the effect of enzymatic hydrolysis on proteins, samples 
were analyzed by RP-HPLC with a C18 column matrix. Fractions were 
collected from the RP-HPLC analysis to see whether the observed bioactivities 
were due to peptides. The fractionated samples were Alcalase hydrolysate of 
potato proteins, potato fruit liquid, and concentrate of hydrophobic small 
rapeseed peptides from the Alcalase hydrolysate of rapeseed proteins. To purify 
the ACE inhibitory peptides, the fractions with the highest ACE inhibitory 
activities were successively rechromatographed. The purified peaks were 
subjected to identification with mass spectrometry and the amino acid 
compositions of the peaks were analyzed by the Pico-Tag method (Millipore 
Corporation, 1987). The isolated peptide peaks were analyzed by a MALDI-
TOF/TOF instrument at the Institute of Biotechnology, University of Helsinki 
(potato samples) and at the Department of Food Science, Aarhus University, 
Denmark (rapeseed samples).   
4.8.4 Comparison of the peptide compositions between the two 
rapeseed peptide concentrates (V) 
The peptide compositions of RPHF ph1 and RPHF ph2 – the fractions tested 
on animals – were compared using UPLC-qTOF analysis. The presence of 
selected previously identified ACE inhibitory peptide sequences in the samples 
was measured by a targeted peptide search. The peptide sequences Arg-Ile-Tyr, 
Thr-Phe, Leu-Tyr and Arg-Ala-Leu-Pro were selected for the search according 
to their hypotensive properties reported in the literature and their prevalence in 
the primary sequences of the rapeseed proteins napin and cruciferin. The y-type 
and b-type fragmenting ions of the peptides were used for verification in the 
fragmenting spectrum. 
4.9 Evaluation of the antihypertensive effects in vivo (V) 
The capacity of rapeseed peptide concentrates (RPHF ph1 and RPHF ph2) to 
prevent the development of hypertension was studied in 2K1C rats. Rat blood 
pressure transmitters were used to directly record arterial pressure and heart 
rate. Blood flow to the left kidney was restricted by the Goldblatt model of 
hypertension (two kidney one clip, 2K-1C) leading to hypertension due to renal 
ischemia (Goldblatt, 1964). The experiments were divided into two study 
phases. In the first phase, the model was established and appropriate dose 
ranges for oral administration were determined for the RPHF ph1 and a 
positive control treatment, captopril. Based on the results of the first phase, the 
second study phase was established. The total observation duration was 28 days.  
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4.10 Statistical analysis 
All samples were tested in triplicate, the analyses were repeated and 
experiments were carried out at least twice. One-way ANOVA was used to 
compare the mean ACE inhibitory activities between treatments and samples. 
In animal trial phase 2 the normality of the data was tested with the Shapiro-
Wilk and Equal Variance tests. The statistical significance of differences in the 
mean values of hemodynamic parameters was tested using one-way ANOVA 
followed by the Holm-Sidak Method as a post hoc test. When needed, Kruskal-
Wallis one-way ANOVA followed by Dunn’s Method as a post hoc test was 
used.
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5 RESULTS AND DISCUSSION 
5.1 ACE inhibitory and antioxidant properties of potato 
protein-derived hydrolysates (I) 
5.1.1 ACE inhibition activity 
ACE inhibitory activities of the potato tuber protein extracts and industrial 
by-product fractions before and after hydrolysis are presented in Table 7. 
Generally, the ACE inhibitory capacities of the hydrolysates were high with 
IC50 values between 0.018 and 0.086 mg protein/ml. For comparison with 
plant protein-derived ACE inhibitory IC50 values presented in the current 
literature, 0.076 mg protein/ml and 0.14 mg protein/ml have been reported for 
pea and rice protein-derived hydrolysates, respectively (Vermeirssen et al., 
2003; Li et al., 2007). In the present study, the highest activities were obtained 
with Alcalase hydrolysis, although the differences between the tested proteases 
were minor and not statistically significant (p > 0.5). Exogenous enzymes were 
needed to enhance the ACE inhibitory activity of the protein extracts from 
mature tubers, but protein extracts from immature tubers were found to be a 
particular exception as ACE inhibitory activity increased during autolysis 
without an added enzyme (from 14 to 41%). The result indicated that immature 
potato tubers contain endogenous proteases that are able to digest potato 
proteins into ACE inhibitory peptides. Overall, the ACE inhibitory activities of 
hydrolyzed liquid fraction were significantly higher than hydrolysates of 
protein extracts from tubers.  
However, rather high ACE inhibitory capacity was observed in the liquid 
fraction already before hydrolysis, meaning that, during processing, compounds 
such as phenolic acids, alkaloids and amino acids – in addition to proteins – are 
liberated to the liquid fraction and ACE inhibitory activity might be partly due 
to nonprotein components. 
Thus, the liquid fraction from the potato starch industry was subjected to 
purification of ACE inhibitory peptides by means of isolating the active 
peptides and ensuring the role of peptides in the ACE inhibition. The liquid 
sample was treated with Sep-Pak cartridges prior to fractionation with RP-
HPLC in order to diminish the nonprotein compounds and concentrate the 
sample. The RP-HPLC profile showed rather high complexity of the sample, 
and ACE inhibition activity was observed throughout the first 30 min of elution, 
indicating that the sample contained various ACE inhibitory peptides with 
different hydrophobic properties. The most active peaks were successively re-
chromatographed, and as a result, three purified peptide peaks were subjected 
to MALDI-TOF/TOF analysis, which showed two ions with molecular masses 
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of 704.2 and 850.5 Da. It could be speculated how the current database 
contents and increased information on potato proteins could enhance the 
identification result. The size of ACE inhibitory peptides is known to vary and 
several ACE inhibitory peptides from other sources with corresponding mass 
with the detected ions have been identified (Pihlanto and Korhonen, 2003). 
However, the nonprotein compounds may still have some effect on the results.  
In comparison to the peptides which have induced antihypertensive effects 
in clinical trials, the most extensively studied ACE inhibitory peptides ILE-
PRO-PRO and VAL-PRO-PRO from milk have shown respective IC50 values 
of 0.0019 and 0.0066 mg protein/ml indicating around tenfold higher ACE 
inhibition potential in comparison to potato protein hydrolysates. However, the 
potato samples are complex mixtures of diverse peptides and thus, the 
comparison with the ACE inhibitory activity of pure peptides is not 
straightforward. It also needs to be taken into account, that the in vitro ACE 
inhibitory capacity and antihypertensive effects in vivo do not correlate 
distinctly and thus, the potato peptides need to be investigated in vivo to 
measure the physiological effects on blood pressure.  
5.1.2 Antioxidant activity  
The radical scavenging activity of the protein extracts as well as by-product 
fractions before and after hydrolysis treatments are presented in Table 7. In 
general, enzymatic hydrolysis enhanced the scavenging activity, except for 
sprouted tubers and there were no statistically significant differences among the 
tested proteases. The radical scavenging value expressed as IC50 µg dry 
matter/ml was 15 for the most active hydrolysate, the Alcalase digest of the 
liquid fraction after 2 h of hydrolysis. For comparison, the IC50 value of 
positive control, Trolox, was 3 µg/ml. Overall, the liquid fraction produced 
significantly higher activities than the protein extracts. The results of the ABTS 
measurements were confirmed by the TRAP method, which gave values 
corresponding to those obtained by the ABTS method (oxidation time data not 
shown). The most active sample was the potato liquid Alcalase hydrolysate, 
which produced an antioxidant capacity of 0.48 g dry matter equivalent to 1 
mmol Trolox. Comparison of the present results to those reported in the 
literature for potato samples is not straightforward due to several different 
methods being used for testing antioxidant activity. Furthermore, the results are 
also expressed in a variety of ways, making comparison difficult. The main 
tuber storage protein, patatin, and its hydrolysates prepared by Amano P and 
Pancreatin treatments have been found to exhibit antioxidant activity in a series 
of in vitro tests (Kudoh et al., 2003; Liu et al., 2003). Moreover, Wang and 
Xiong (2005) observed that hydrolysis of potato proteins by Alcalase increased 
their radical scavenging activity. During enzymatic treatment, the increased 
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scavenging activity probably correlates with the structural changes of proteins 
and release of peptides. It has been reported that accessibility to the oxidant-
antioxidant test system is greater for small peptides and amino acids than for 
large peptides and proteins (Moosman and Behl, 2002). However, the role of 
nonprotein compounds in the observed antioxidant activity cannot be neglected. 
Previous research has shown that potato contains antioxidative compounds, 
such as ascorbic acid (Dale et al., 2003) and phenolic compounds, but fairly 
low antioxidant activity has been obtained by the TOSC assay (Friedman, 1997; 
Chu et al., 2002). According to current published data, the radical scavenging 
activity of the peel fraction was most likely due to the phenolic compounds 
(Nara et al., 2006). 
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5.1.3 Production of ACE inhibitory peptides from potato protein 
extracts by autolysis (II) 
Potato protein extracts of whole tubers, vascular tissue-enriched fractions, pith 
fractions and peel fractions of the tubers at different physiological stage were 
autolyzed and the effect of autolysis treatment on ACE inhibitory activity was 
measured. Prior to autolysis, the proteolytic activities of the protein extracts were 
measured with amino acid p-NA substrates in order to characterize the peptidase 
activities of the extracts. The results showed that both physiological age and 
tuber tissue fraction affect remarkably the ACE inhibition production during the 
autolysis as well as in the peptidase activities (Figure 5). In general, the highest 
increase in ACE inhibitory activity was found in the pith fractions in comparison 
to whole tubers, and vascular tissue fractions. The autolytic activity was at its 
highest in the dormancy braking stage after five months’ storage and prior to 
sprouting (Figure 5B). After sprouting the autolytic activity was transferred into 
the vascular tissue fraction (Figure 5C).  
 
       
        
Figure 5 Increase of ACE inhibitory activity following autolysis of protein 
extracts and the respective peptidase activities from (B) pith fractions and (C) 
vascular tissue-enriched fractions. The lower edge of the ACE inhibition bar 
shows the activity prior to autolysis and the upper edge after autolysis. Tubers 
were sampled at different physiological ages: 3 harvest time; 4 dormancy; 5 
dormancy braking; 6 prior to sprouting; 7 sprouted tubers. 
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Proteolytic activities of the protein extracts were in positive correlation with 
production of the ACE inhibitory activity. The highest peptidase activities were 
observed at dormancy braking prior to sprouting, whereas in the dormant stage 
tubers the proteolytic activity was at its lowest (Figure 5). The peptidase 
activities were concentrated in the innermost part of the tubers (Figure 5B) 
although during the dormancy braking and sprouting peptidase activity was 
also detected in the vascular tissue fractions (Figure 5C). The peptidase 
activities were highest in proline- and leucine-derived substrates among the 
tested amino acid derivatives, which is particularly interesting as proline at the 
C terminus of peptides seems to be especially effective in increasing the ACE 
inhibitory potential (Murray and FitzGerald, 2007).  
Taken together, the data suggested that the bulk of autolytic activity 
resulting in enhanced ACE inhibition is largely confined to the internal part of 
the tuber consisting of inner phloem and pith tissue. Thus, peeling potatoes or 
storing them until the break of dormancy does not lower their value as a source 
of ACE inhibitory peptides. The current literature shows consistently that the 
developmental stage and physiological age of potato tubers are associated with 
significant alterations in the protein composition of potato tubers (Borgmann et 
al., 1994; Desires et al., 1995a; Desires et al., 1995b; Espen et al., 1999; 
Kumar et al., 1999; Lehesranta et al., 2006). The results of the present study 
associate these differences in the production of ACE inhibitory activity.  
5.1.3.1 Protein enrichment in the autolysis reaction 
The protein extract with the highest proteolytic activity and the greatest 
increase in the ACE inhibitory activity during the autolysis was amended with 
a recombinant potato protein predicted to produce six Val-Pro-Pro peptides per 
molecule. Addition of the recombinant protein resulted in a significant increase 
(p < 0.01) in the ACE inhibition activity during the autolysis (Figure 6). The 
observed effect was dependent on the concentration of recombinant protein: a 
5 % addition produced an increase of 10.4 % in ACE inhibition in comparison 
to nonamended autolysis whereas a 2 % addition resulted in a 5 % increase 
(Figure 6 A,B). For comparison, the addition of BSA increased the ACE 
inhibition only slightly. The effect of total potato protein concentrate addition 
enhanced the production of ACE inhibitory compounds during the autolysis 
consistently. The addition of the total protein concentrate resulted in a 10 % (p 
< 0.01) increase in the ACE inhibition (Figure 6 C). The added protein 
concentrate was a retentate from membrane filtration with 10 000 Da MWCO 
of the corresponding protein extract of pith fraction. 
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Figure 6 Effects of the addition of purified recombinant protein (A) 5 or (B) 2% 
(w/v) or tuber pith fraction protein concentrate (C) 10% (w/w) on the 
production of ACE inhibitory activity during autolysis treatment. Buffer was 
added as the control, and the relative changes in ACE inhibition activity were 
compared to this control sample. Thin bars indicate standard error (three 
autolysis reactions with two replicates; n=6). 
Taken together, amendment of putative protein sources for the release of 
bioactive ACE inhibitory peptides enhanced significantly ACE inhibition 
production during autolysis. As little as 2 to 5 % of the recombinant protein in 
the total protein content, caused a significant increase in ACE inhibition. Thus, 
the results show conceivably that the observed increase of ACE inhibition was 
due to bioactive peptides released from proteins during autolysis. However, 
nonprotein compounds such as phenolics or salts in the protein extracts could 
also play a minor role in the inhibition of ACE. 
5.1.3.2 Identification of proteins degraded during autolysis 
Proteins of the most proteolytic pith fraction were analyzed by 2D 
electrophoresis before and after autolysis to detect putative sources of bioactive 
peptides associated with the observed ACE inhibition. Many protein spots were 
observed to diminish during the autolysis treatment (Figure 7). A group of proteins 
that corresponded approximately to 20 kDa and was very pronounced prior to 
autolysis was hardly detectable after autolysis. Two degrading proteins were 
identified as potato aspartic protease inhibitors. This indicates that endogenous 
potato proteases can degrade potato protein inhibitors into ACE inhibitory 
peptides when released from cellular structures. According to published data, 
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various protein inhibitors constitute up to 50% of the total tuber proteins 
(Pouvreau et al., 2001; Lehesrant et al., 2006), which makes them a very potential 
substrate for the release of ACE inhibitory peptides. The protein inhibitors target 
different classes of proteases and they have also been reported to degrade during 
the ageing of potato tubers non-enzymatically (Kumar et al., 1999). Furthermore, 
we observed a consequent increase in the proteolytic activity during ageing. In 
summary, there is scope for native endogenous proteases to be active and use 
protease inhibitors as substrates for the release of bioactive peptides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 Degradation of proteins during the autolysis of potato tuber pith 
fraction protein extract. The proteins in the marked area were identified as 
aspartic proteases. M = protein size marker. 
5.2 ACE inhibitory properties of rapeseed protein-derived 
hydrolysates and fermented samples (III, IV, V) 
5.2.1 Chemical characterization of samples (III)  
The proximate composition of the rapeseed by-product was 35% dry matter, 
of which 88% was protein, and 7 µmol/g glucosinolates, and the content of 
condensated tannins was 174 mg/100 g fresh weight. For comparison, Naczk et 
al. (1994) reported tannin concentrations of a few hundred mg/100 g fresh 
weight of hulls. Among the seven different glucosinolates identified, 
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progoitrine (4.5 µmol/g) and gluconapine (1.6 µmol/g) were the dominant ones. 
Glucosinolates and tannins were diminished during the hydrolysis treatment, as 
no glucosinolates or condensed tannins were detected after hydrolysis. Small 
amounts (<100 µg/ml) of sinapic acid derivatives and some unknown 
flavonoids were present in the hydrolyzed samples. 
5.2.2 ACE inhibitory activity of the hydrolyzed and fermented 
samples (III, IV). 
The ACE inhibitory activities in vitro of rapeseed samples after hydrolysis 
and fermentation treatments are presented in Table 8. All enzymatic 
hydrolysates showed high ACE inhibitory activity of which the Alcalase 
hydrolysate had the highest ACE inhibitory capacity with an IC50 value of 0.02 
mg protein/ml. Differences between the tested enzymes were minor. For 
comparison to other published data, Marczak et al. (2003) reported an IC50 
value of 0.16 mg protein/ml for rapeseed Subtilisin hydrolysate and He et al. 
(2013a) reported ACE inhibitory activities around 80% for rapeseed protein-
derived hydrolysates at 1 mg protein/ml. The glucosinolates and phenolic 
compounds were found to diminish during the hydrolysis treatment, but in any 
case, the effects of other nonprotein compounds such as salts and free sugars in 
the ACE inhibitory measurement cannot be neglected.  
Table 8 ACE inhibitory activities and inhibition of lipid peroxidation by 
rapeseed protein-derived hydrolysates and fermented samples (n  ≥ 3) 
Sample ACE inhibition Inhibition of lipid peroxidation 
 IC50 mg/ml protein Inhibition %b IERc (%/mg/ml) 
Hydrolysates    
Pepsin pH 2 40 °C 3 h 0.06 65.0 ± 2.2 139 
Subtilisin pH 8 60 °C 3 h 0.07 62.5 ± 4.4 125 
Alcalase pH 7 55 °C 3 h 0.02 77.3 ± 0.3 145 
Thermolysin pH 8 60 °C 3 h ND 59.6 ± 5.7 119 
Trypsin pH 7 40 °C 3 h ND 72.8 ± 5.0 151 
Control pH 7 40 ˚C 3 h ND 67.6 ± 0.4 195 
Fermented samples    
B.subtilis 48 h 0.58 100 ± 2.1 17.9 
K.marxianus 48 h ND 100 ±12.4 20.8 
Lact. helveticus  48 h 0.42 100 ±10.7 20.8 
L.lactis 48h ND ND ND 
Captopril 1.3 x 10-6   
aThe protein concentration in the analysis was 1mg/ml; bthe protein 
concentration in the analysis varied between 0.35 and 0.58 mg/ml; cIER, 
inhibitory efficience ration = % inhibition/protein content. 
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The effects of L. helveticus, B. subtilis, L. lactis and K. marxianus 
fermentation treatments on the ACE inhibition and antioxidant activites are 
presented in Table 8. Lactic acid bacteria grew well in the medium as the pH 
decreased substantially from 6.0 to 3.7 during fermentation. The highest increase 
in ACE inhibition capacities was found with L. helveticus and B. subtilis with 
IC50 values of 0.42 mg protein/ml and 0.58 mg protein/ml, respectively. In the 
published data, L. helveticus strains are widely reported for their ability to release 
ACE inhibitory peptides and for their strong proteolytic effects. The proteolytic 
effects of the fermentation treatments on the rapeseed proteins are presented in 
Table 9 on page 70. Characterization of the samples. The importance of strong 
proteolytic activity has been related to the ability of certain strains to produce 
bioactivities such as ACE inhibitory peptides. However, it should be noted that 
higher activities have been found when further enzymatic treatment is combined 
with fermentation (Vermeirssen et al., 2003; Gibbs et al., 2004), and moreover, 
enzymatic hydrolysis alone has been shown to produce potent antihypertensive 
hydrolysates from plant proteins, as was also observed in the present study. 
Altogether, the results consistently show the high potential of rapeseed meal as a 
source of ACE inhibitory peptides and the efficacy of enzymatic hydrolysis, 
especially with Alcalase, for the release of ACE inhibitory peptides. 
5.2.3 Concentration of ACE inhibitory peptides (III)  
The peptides in the rapeseed protein-derived Alcalase hydrolysate were 
subjected to concentration with solid-phase extraction and ultrafiltration. ACE 
inhibitory compounds were slightly concentrated in the hydrophobic fraction 
eluted between 30% and 60% solvent B (90% ACN, 0.1% TFA), as the IC50 
value of this fraction was 0.13 mg protein/ml, whereas the corresponding value 
for the fraction eluted between 10% and 30% solvent B was 0.27 mg protein/ml. 
Both fractions were subjected to ultrafiltration with a 3 000 Da MWCO 
membrane in order to separate small peptides from intact proteins and large 
polypeptide chains. As a result, the ACE inhibitory peptides were efficiently 
concentrated into the permeate of the hydrophobic fraction with an IC50 value of 
0.08 mg protein/ml. Meanwhile, the IC50 value for the permeate of the less 
hydrophobic fraction was 0.32 mg/ml. According to current literature, 
hydrophobic amino acids play an integral role in ACE inhibition and on the other 
hand, ACE inhibitory peptides are generally short sequences as the active site of 
ACE cannot accommodate large peptide molecules. The results of the present 
study support the previously published data, as the ACE inhibitory activity was 
found to increase in positive correlation with hydrophobicity and small size.   
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5.2.4 Mechanism of ACE inhibition (III)  
All rapeseed samples showed mixed-type inhibition characteristics. The Ki 
value, which indicates the affinity of peptides to the active site of ACE, was for 
the concentrate of small hydrophobic rapeseed peptides 0.154 mg protein/ml. For 
comparison to the reported literature, fermented whey has shown a Ki value of 
0.188 mg/ml (Tsai et al., 2008b) and a flaxseed protein hydrolysate of 0.0128 
mg/ml (Udenigwe et al., 2009). On the other hand, the hypotensive drug Captopril 
has shown a Ki value of 0.0067 mg/ ml (Tsai et al., 2008b) indicating a much 
stronger affinity to the active site of ACE. In general, the most frequently observed 
type of ACE inhibitory mechanism has been competitive, for example Captopril is 
known to be a competitive inhibitor. However, noncompetitive and uncompetitive 
ACE inhibition mechanisms have also been reported (Pedroche et al., 2002; 
Barbana and Boye, 2010). The mixed-type inhibition of rapeseed samples of the 
present study was presumably due to the heterogeneity of the samples indicating 
the presence of various peptides with different inhibition characteristics. 
5.2.5 Resistance of ACE inhibitory activity to proteolysis in the 
digestion model (III)  
The rapeseed protein-derived Alcalase hydrolysate was subjected to in vitro 
digestion treatment with human digestive liquids to estimate the potential of 
rapeseed peptides to avoid structural degradation and loss of ACE inhibitory 
activity in the gastric and duodenal digestion. The ACE inhibitory activity 
remained quite stable throughout treatment; the IC50 value changed from 9 to 14 
µg protein/ml (Figure 8). The results from microfluid protein electrophoresis 
revealed that only minor protein fragments in the Alcalase hydrolysate were 
digested during the treatments, indicating the resistance of ACE inhibitory 
rapeseed peptides to proteolysis in the gastric and duodenal digestion. 
 
 
 
Figure 8 Stability of ACE inhibitory activity of rapeseed hydrolysate sample in 
simulated digestion treatment, and the corresponding protein patterns from 
microfluid electrophoresis. Start=before digestion, HGJ=after 30 min treatment with 
human gastric liquid, HDJ=after 30 min treatment with human duodenal liquid. 
ACE inhibition IC50 µg protein/ml   
          9              14            14 
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In general, the bioavailability of peptides is a major factor for their potential 
in vivo effects. If the protein hydrolysate is orally ingested, it is important to 
determine the possible loss of ACE inhibitory activity with simulated 
gastrointestinal digestion in vitro. If the activity decreases substantially during 
digestion, it is unlikely that further in vivo evaluations would be made, to 
prevent unnecessary use of animals. Commercial enzymes have been shown to 
possess proteolytic properties that differ from human digestive fluids (Eriksen 
et al., 2010). The proteolytic system in human digestive fluids is highly 
complex and not thoroughly known as yet, and thus the use of human fluids 
yields more precise information than commercial enzymes.  
Taken together, the results of the present study showed that the most active 
ACE inhibitory peptides in the Alcalase hydrolysate of rapeseed protein were 
hydrophobic and rather small, and furthermore, the ACE inhibition was found 
to be stable in the simulated digestion. In other words, the ACE inhibitory 
rapeseed peptides can potentially be preserved in the gastrointestinal tract and 
be absorbed in active form. In any case, measurement of the antihypertensive 
effects is needed to evaluate the potential in vivo antihypertensive effects. 
5.2.6 Inhibition of lipid peroxidation (III, IV)  
The effects of enzymatic hydrolysis on in vitro inhibition of lipid 
peroxidation of rapeseed isolates are presented in Table 8. All the hydrolysates 
inhibited lipid peroxidation by percentages above 50 %, indicating rather high 
antioxidant capacity. Enzymatic hydrolysis enhanced the inhibitory capacity 
against lipid peroxidation, but there were no significant differences between the 
tested enzymes. Additionally, we studied the effect of fermentation on in vitro 
lipid peroxidation. All tested fermented samples inhibited lipid peroxidation 
above 50 % (Table 8), in line with the hydrolyzed samples. Fermentation with 
L. helveticus produced slightly higher potencies when the results were 
calculated against protein concentration. It is quite difficult to compare results 
to the previously reported data due to various assay systems being used to 
measure antioxidant capacities. Most of the studies have used different radical 
scavenging assays and we assayed the inhibition of lipid peroxidation. The 
assay was selected due to the importance of oxidative deterioration of 
polyunsaturated lipids leading to a wide range of cytotoxic products. In any 
case, antioxidant activities have been reported for rapeseed protein-derived 
hydrolysates: for example, dose-dependent reducing antioxidant power and 
hydroxyl radical scavenging activity (Xue et al., 2009; He et al., 2013a).  
In general, the amino acid composition of proteins and peptides has been 
found to affect their antioxidant capacity. In the present study, the increased 
antioxidant activity due to hydrolysis indicates the role of peptides and amino 
acids released during hydrolysis, and the effect of fermentation with  
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L. helveticus for enhancing antioxidant capacity is presumably related to the 
high proteolytic activity of L. helveticus and consequent formation of small 
molecular-weight degradation products during fermentation. However, 
nonprotein compounds such as phenols and pigments need to be taken into 
account when evaluating the antioxidant activities of rapeseed samples. 
According to our results, the content of tannins and glucosinolates after 
hydrolysis by proteolytic enzymes was close to zero, but the presence of some 
phenolic compounds such as sinapic acid derivatives was observed. Thus, 
further fractionation studies are necessary to identify the antioxidant peptides 
present in rapeseed hydrolysates and fermented samples. 
5.2.7 ACE inhibitory properties of rapeseed protein-derived peptide 
fractions subjected to in vivo studies (V)  
Based on the previously described results, the concentrate of hydrophobic 
small rapeseed peptides was prepared for in vivo studies by means of solid-
phase extraction and membrane filtration. At this time, concentration was 
performed in larger volumes than the previously reported concentration and the 
hydrophobic fraction was eluted between 15 and 60 % of ACN. The ACE 
inhibition IC50 value obtained after the solid-phase extraction was 0.531 mg 
protein/ml for the fraction eluted between 15 and 60 % ACN and ultrafiltration 
with a 3 000 Da MWCO membrane concentrated the ACE inhibitory peptides 
into the permeate; the ACE inhibitory IC50 value of the permeate, designated 
as RPHF ph1, was 0.375 mg protein/ml. This fraction was subjected to the first 
phase of in vivo study on animals. Subsequently, the hydrolysis and 
concentration procedure was repeated in order to generate an adequate amount 
of rapeseed peptide concentrate for the animal test phase 2. The procedure was 
identical to that conducted previously, but the milled rapeseed used as raw 
material was obtained from another industrial batch. The ACE inhibitory 
activity of the fraction was slightly weaker this time; the IC50 value of the 
hydrophobic small peptide fraction, designated as RPHF ph2, was 0.470 mg 
protein/ml. For comparison to published data, He et al. (2013a) reported 
consistent ACE inhibitory activity with RPHF ph1 and RPHF ph2 for small 
molecular-weight ultrafiltration fractions of rapeseed protein-derived Alcalase 
(ACE inhibition of 80 – 90 % with 1 mg protein/ml).  
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5.3 Characterization of the samples 
5.3.1 Size-exclusion chromatography (III, IV) 
Size-exclusion chromatography was utilized to determine the degradation of 
proteins during the hydrolysis and fermentation treatments. Enzymatic 
hydrolysis degraded >10 kDa proteins effectively into <5 kDa degradation 
products, although Thermolysin was less proteolytic than Alcalase, trypsin and 
Subtilisin (Table 9). During fermentation, proteins were hydrolyzed by the 
extracellular proteinases of the microbes, resulting in an increase of small 
molecular-weight compounds. The effects differed among the microbial strains: 
K. marxianus and L. lactis were not proteolytically active as no significant 
degradation of proteins was observed with either of the strains, whereas B. 
subtilis and L. helveticus degraded efficiently the high molecular-weight 
proteins (Table 9). In particular, L. helveticus produced a high amount of 
degradation products with molecular mass below 1 kDa. The results showed 
that the ACE inhibitory activity is distinctly correlated with the efficacy of 
proteolytic treatment and proportion of small degradation products. 
 
Table 9 Proteolytic effects of microbial fermentations on rapeseed proteins 
Treatment 
Molecular weight distribution (kDa)% 
< 1 1.01 - 5.0 5.01 - 10.0 >10 
Rapeseed 0 h 13.8 23.4 21.1 30.0 
B.subtilis 48 h 16.1 29.6 53.1 0 
K.marxianus 48 h 15.3 27.2 22.4 29.2 
Lact. helveticus  48 h 22.2 32.2 41.9 2.9 
L.lactis 48 h 13.7 24.3 22.5 37.8 
To see that the observed increase in bioactivities is due to peptides produced 
during fermentation with L. helveticus, fractions were collected from gel 
filtration chromatography. The highest ACE inhibitory potencies were found in 
small molecular-weight 300 – 500 Da fractions, whereas the inhibition of lipid 
oxidation was found mostly in 1 200 – 1 300 Da fractions (see Figure 9).  
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Figure 9 The molecular size profile of rapeseed meal fermented by L. 
helveticus for 48 h at 37 °C. The lines correspond to fractions with ACE 
inhibitory or inhibition of lipid peroxidation. This profile is representative of 
several runs that were carried out. The columns show ACE inhibition%, 
inhibition of lipid peroxidation%, and protein concentration mg/mL in 
collected fractions. 
The results indicate that the most potent peptides inhibiting lipid 
peroxidation have a molecular mass of 1 200 – 1 300 Da and the most effective 
ACE inhibitory peptides are of 300 - 500 Da in molecular size. Several ACE 
inhibitory peptides with corresponding molecular mass have been reported in 
the current literature, for example rapeseed protein-derived peptide Arg-Ile-Tyr 
(450.54 Da, Marczak et al., 2003). For comparison to antioxidative peptides in 
the current literature, peptides with molecular masses consistent with the 
present results have been identified for example, from whey of 1 200 Da 
(Hernandez-Ledesma et al., 2005), giant squid muscle of 747 and 1 307 Da 
(Rajapakase et al., 2005), and chicken essence of 1 400 Da (Wu et al., 2005). 
However, the amino acid content should be analyzed to see whether the 
activities are due to specific amino acid residues. 
5.3.2 Reversed-phase chromatography (V) 
The rapeseed peptide concentrate RPHF ph1 was fractionated by RP-HPLC 
chromatography in order to isolate the ACE inhibitory peptides. ACE 
inhibitory activity was widely observed in all of the fractions, indicating the 
presence of several ACE inhibitory peptides with a wide range of 
hydrophobicity. Four fractions possessed the highest ACE inhibition, 86 to 
89 %, and these fractions were successively re-chromatographed several times. 
Purified peptide peaks were collected and subjected to MALDI-TOF/TOF 
analysis for identification. As a result, the peaks of the MS/MS spectra with a 
positive charge ion at m/z 1139.64 and 1008.69 were identified as  
Ser-Ser-Val-Ser-Pro-Ser-Ala-Ala-Ala-Ala-Ala-Ala-Pro-Gly-Gly-Ser and Lys-
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Lys-Arg-Ser-Lys-Lys-Lys-Ser-Phe-Gly, respectively, with respective 
molecular weights of 1139 Da and 1008 Da. In general, the RP-HPLC and 
MALDI-TOF/TOF analysis showed that the ACE inhibitory potency of RPHF 
ph1 was due to several ACE inhibitory peptides with a wide range of 
hydrophobicity. The identified peptides are presumably not very effective ACE 
inhibitors as such due to their large size. However, they contain primarily 
hydrophobic amino acid residues and may degrade into more efficient ACE 
inhibitors during gastrointestinal digestion. 
5.4 Preventive effects against hypertension of rapeseed 
peptide fractions in 2K1C rats (V) 
In order to measure the antihypertensive effects, rapeseed peptide 
concentrates (RPHF ph1 and RPHF ph2) were evaluated in vivo using oral 
administration to 2K1C rats. The mean arterial pressure (MAP) of the rats was 
recorded by using a radiotelemetry method (Tonkiss et al., 1998). 
5.4.1 First phase of the study  
The RPHF ph1-treated (600 mg/kg body weight) rats showed lower MAP 
values than vehicle-treated rats and it was observed that the RPHF ph1 
prevented the elevation of MAP in the 2K1C model (Figure 10). The maximum 
reduction in the systolic blood pressure (SBP) of the RPHF ph1, -50 mmHg, 
was observed after ten days of dosage and the preventive effect of RPHF ph1 
on the elevation of MAP could be seen throughout the 28 days of the study. 
The respective antihypertensive effect of the positive control, Captopril, after 
ten days of dosage was -70 mmHg. The number of animals per group used in 
this study phase (n=4) was too small to perform formal statistical analysis and 
the observations are based on differences between the means ± SEM.  
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Figure 10 Effects of RPHF ph1 on the blood pressure of 2K1C animals (n=4), 
values expressed as MAP±SEM. 
5.4.2 Second phase of the animal study 
Based on the results of phase 1 of the study, a further study with a larger 
number of animals per group (n=6) was established. The results are presented 
in the Figure 11. Overall, the results from phase 2 of the animal study were 
partly incoherent with the results of phase 1 with the RPHF ph1. The RPHF 
ph2 was observed to prevent blood pressure elevation in 2K1C rats to some 
extent, but the effect was weaker than with the RPHF ph1 in the first study 
phase and not statistically significant. 
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Figure 11 Effect of RPHF ph2 on blood pressure in 2K1C animals (n=6), 
values expressed as MAP±SEM. 
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The current literature includes information on the hypotensive effects of 
plant protein-derived hydrolysates and peptides, rapeseed peptides among them, 
but the previously reported hypotensive effects have been measured on the 
SHR model, and thus the comparison with the present study is not 
straightforward. For example, the increase of vascular mass in SHR may have a 
role when comparing the results to 2K1C model rats (Fouda et al., 1987). 
However, some correlation with the previously demonstrated hypotensive 
effects of plant protein-derived hydrolysates and peptides can be found. For 
example, corresponding SBP reductions with the RPHF ph1 have been 
demonstrated for rapeseed protein-derived Alcalase hydrolysate (100 mg/kg bw) 
with a decrease in SBP of -24 mmHg at 8 h after oral administration to SHR 
(He et al., 2013a) and for 3 000 Da membrane ultrafiltration permeate of a 
rapeseed protein-derived Pepsin+Pancreatin digest with an SBP reduction of 
about -21 mmHg after 4 h of oral administration (100 mg/kg bw) to SHR (He et 
al., 2013a). For comparison to the antihypertensive effects of plant protein-
derived hydrolysates of other origins, an SBP reduction of around -20 mmHg 
has been reported after oral administration (100 mg/kg bw) of sweet potato 
protein hydrolysate to SHR (Ishiguro et al., 2012). The SBP reductions 
observed with the RPHF ph1 were more pronounced than the previously 
reported antihypertensive effects, but with a relatively higher dose of 600 
mg/kg bw. However, it needs to be emphasized that comparison of the results is 
not straightforward due to the different model used. The premise of the current 
study was preventive and the effects of the rapeseed peptide fraction on blood 
pressure were detected for a longer period in comparison to the previously 
reported studies on SHR. Overall, the present results indicate preventive 
potential against hypertension for rapeseed protein-derived peptides. 
5.4.3 Comparison of the peptide compositions of the two rapeseed 
peptide concentrates  
Due to the incoherent results from the in vivo studies, the peptide 
compositions of RPHF ph1 and ph2 were analyzed by UPLC-qTOF/TOF. The 
results showed that the samples were composed of a highly complex mixture of 
peptides and demonstrated also that the compositions between the two samples 
were similar in the majority. However, a targeted search for the previously 
identified rapeseed peptides Arg-Ile-Tyr, Thr-Phe, Leu-Tyr and Arg-Ala-Leu-
Pro revealed differences between the RPHF ph1 and RPHF ph2. Peptide Arg-
Ile-Tyr was detected in both of the samples as well as Leu-Tyr, but Thr-Phe 
was found only in the RPHF ph1 and not in the RPHF ph2, indicating that the 
peptide compositions of RPHF ph1 and PFH ph2 were not identical.  
Taking the results from animal studies and targeted peptide analysis together, 
it can be considered that the reason for the incoherent in vivo results from study 
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phase 1 and phase 2 may lie at least partly in the peptide composition of the 
samples. The ACE inhibitory IC50 values of the RPHF ph1 and RPHF ph2 
used for animal study phase 1 and phase 2, respectively, were not equal 
although they were rather close. The predominant peptide compositions of the 
two RPHF were found to be correspondent, but a specific difference was 
observed concerning peptide THR-PHE with an IC50 value of 3.061 mM. This 
dipeptide has been previously reported to possess antihypertensive properties in 
vivo in SHR. The observed specific difference in the peptide composition is 
presumably at least partly responsible for the weaker antihypertensive effects 
of the RPHF ph2, but there may also be other specific differences between the 
two samples. Further extensive analysis of peptide compositions would be 
needed to measure the differences throroughly. The peptide compositions of 
RPHF ph1 and RPHF ph2 may differ basically for two reasons: the sample 
preparation process and the milled rapeseed used as raw material. The RPHF 
ph1 and RPHF ph2 were prepared separately in different volumes – although 
both at the laboratory scale – and this may result in some differences in the 
hydrolysis and fractionation of peptides. However, an essential factor for the 
peptide composition is presumably the milled rapeseed used as raw material. 
The milled rapeseed was manufactured in different years for the RPHF ph1 and 
RPHF ph2 and this may cause differences in the extensive protein composition 
of the raw material used for the hydrolysis. To summarize, the results indicate 
that the final hypotensive capacity of rapeseed peptide concentrates is 
potentially a result of synergistic actions of several peptides, and that the raw 
material quality has a particular effect on the final peptide composition.  
5.5 Some aspects concerning practical applications of plant 
protein-derived antihypertensive peptides 
Plant-derived bioactive peptides possess a widely documented 
antihypertensive potential in vitro, but thus far the data concerning the 
antihypertensive effects in vivo is limited to rather few studies on animals. In 
general, few commercial product applications have been established with 
antihypertensive milk peptides. The most studied milk peptides Val-Pro-Pro 
and Ile-Pro-Pro have shown antihypertensive effects in several studies on 
animals and human subjects, but the effects have not been unambiguous. The 
extent of the antihypertensive effects has been suggested to depend on the 
nature of delivery system, dose, study duration, genetic background of the 
subjects, stages of hypertension (reviewed by Udenigwe and Aluko, 2012). 
Much emphasis has been put on the legal regulation of the health claims 
attached to the products. Systematic approaches for the review and assessment 
of scientific data have been developed by authorities around the world. In the 
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EU, the European Regulation on nutrition and health claims was established in 
January 2007 and the regulations are governed by EFSA. Recently, the aspects 
concerning the scientific information needed  for the use of a health claim in 
the functional food product labeling and marketing were summarized as 
follows (reviewed by Pihlanto and Mäkinen, 2013): 
 The scientific evidence on the beneficial effects of the product needs to 
be sufficiently detailed, extensive and conclusive: 
 It is necessary to identify and quantify the active sequences in the 
product. It is mandatory to monitor the hydrolytic or fermentative 
industrial production process as the antihypertensive peptides are only 
minor constituents in highly complex food matrices.  
 The antihypertensive effect in humans as well as the minimal dose 
needed to show the effect have to be proven in extensive investigations 
to fulfill the requirements of the legislation concerning functional foods.  
In general, the feasibility of the food protein-derived bioactive peptides 
depends on the bioavailability in intact forms in target tissues, which in turn 
depends on the structure of the peptides. Information on the important 
structure-function parameters of peptides is increasing constantly, which can 
greatly enhance the production and processing of peptides. To enable sufficient 
scientific evidence on the antihypertensive effects of the plant protein-derived 
peptides, there is a crucial need for further research on the elucidation of the in 
vivo molecular mechanisms of action, safety at various doses, and 
pharmacological activity in the prevention of abnormal health conditions in 
human subjects. Recent advances in specific analytical techniques enable these 
measurements as they have made it possible to follow small amounts of the 
peptides and derivatives in biological fluids and complex matrices. At the same 
time, emphasis has been put on developing technological tools to enhance the 
bioavailability of these peptides. A great technological challenge is also to 
develop food industry-applicable large-scale processing methods for 
concentration of the active peptides according to the structure-function 
parameters, leading to high-yield peptide products. These findings and 
challenges open up an interesting field aimed at the revaluation of the protein-
rich by-products formed in the food industry. 
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6 SUMMARY AND CONCLUSION 
Hydrolysis of defatted rapeseed meal from the rapeseed oil industry by 
proteolytic enzymes, Alcalase being the most effective among them, produced 
high in vitro ACE inhibitory activity as well as activity against lipid oxidation. 
Protein extraction and hydrolysis treatments effectively removed anti-
nutritional compounds such as glucosinolates from rapeseed meal. 
Fermentation of rapeseed meal with L. helveticus and B. subtilis strains also 
produced peptides with ACE inhibitory activity and inhibition capacity against 
lipid peroxidation, but the efficacy of fermentation was minor in comparison to 
enzymatic hydrolysis. ACE inhibition was mainly due to low molecular-weight 
peptides (300 - 500 Da) whereas inhibition of lipid peroxidation was due to 
higher molecular-weight peptides (1 200 – 1 300 Da). 
The ACE inhibitory activity of rapeseed protein-derived Alcalase 
hydrolysate remained stable in treatment with human gastric and duodenal 
fluids, and ACE inhibition was concentrated in the fraction of small 
hydrophobic peptides. This indicated the potential bioavailability of the 
produced peptide concentrate, and thus the potential antihypertensive effects of 
the peptide fractions were tested in vivo on animals. The results indicated that 
the concentrate of small hydrophobic rapeseed peptides may possess preventive 
effects against the elevation of blood pressure after oral administration to 2K1C 
rats. However, the results demonstrated, in particular, the essential effect of the 
quality of milled rapeseed used as a raw material on the peptide composition 
obtained after hydrolysis. Two peptides, which may be precursors of ACE 
inhibitory peptides, were identified from the hydrophobic, small molecular-
weight rapeseed peptide concentrate.  
Hydrolysis of industrial by-products from potato starch production and 
potato tuber protein extracts with commercial proteolytic enzymes yielded 
effective ACE inhibition capacity and radical scavenging activity. Among the 
tested enzymes, Alcalase produced the highest ACE inhibitory activities with 
corresponding values to rapeseed protein-derived Alcalase hydrolysate. The 
highest antioxidant activities were also observed in samples hydrolyzed with 
Alcalase. Overall, potato fruit liquid from the potato starch industry yielded 
higher ACE inhibitory and antioxidant activities than the other potato fractions. 
The ACE inhibitory activity was most likely related to peptides released during 
the enzymatic hydrolysis, but phenolic compounds were at least partly 
responsible for the antioxidant activity of potato by-product fractions. 
In addition to enzymatic treatments, autolysis was found to enhance ACE 
inhibition of potato tuber extracts. Protein extracts from inner tuber tissues of 
potato showed particular autolytic capacity. The physiological age of the tuber 
affected the production of ACE inhibition production during the autolysis; the 
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highest autolytic activity was observed in stored tubers at dormancy braking. 
The production of ACE inhibitory activity was positively correlated with 
protease activity in tuber tissues. Amendment of the autolysis reaction with 
protein substrates from which bioactive ACE inhibitory peptides may be 
released enhanced ACE inhibition. Many tuber proteins including aspartic 
protease inhibitors were observed to degrade during autolysis. The results 
showed that the observed increase in ACE inhibition was conceivably due to 
bioactive peptides released from proteins during autolysis.  
Altogether, the results indicate that rapeseed and potato proteins are rich 
sources for the production of bioactive peptides with ACE inhibitory and 
antioxidant properties. Moreover, food industry by-products have the additional 
advantage of representing a value-added outlet for inexpensive starting material. 
Further studies are still required to identify the active peptides and to 
investigate the in vivo antihypertensive effects of the peptides. An economic 
analysis of the whole process from the collection of by-products to the 
production of the powered peptide mixture would provide valuable information 
for the food industry. 
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